{"idB": "1316175_12_item1a_p24_s0", "idA": "1316175_11_item1a_p103_s0", "sentA": "Government agencies issue regulations and guidelines directly applicable to us and to our product candidates.", "sentB": "SLE response index and to include an option for an interim efficacy analysis.", "type": 1, "words": ["<tag1>", "Government", "agencies", "issue", "regulations", "and", "guidelines", "directly", "applicable", "to", "us", "and", "to", "our", "product", "candidates.", "<tag2>", "SLE", "response", "index", "and", "to", "include", "an", "option", "for", "an", "interim", "efficacy", "analysis.", "<tag3>"], "wordsA": ["Government", "agencies", "issue", "regulations", "and", "guidelines", "directly", "applicable", "to", "us", "and", "to", "our", "product", "candidates."], "wordsB": ["SLE", "response", "index", "and", "to", "include", "an", "option", "for", "an", "interim", "efficacy", "analysis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item1a_p140_s0", "idA": "1316175_11_item1a_p103_s1", "sentA": "In addition, professional societies, practice management groups, private health or science foundations and organizations involved in various diseases from time to time publish guidelines or recommendations to the medical and patient communities.", "sentB": "We filed a universal shelf registration statement with the SEC on Form S-3 (File No. 333-179043) on January 17, 2012, which was declared effective on January 24, 2012, for the proposed offering from time to time of up to $100.0 million of our securities, including common stock, preferred stock, debt securities and/or warrants.", "type": 1, "words": ["<tag1>", "In", "addition,", "professional", "societies,", "practice", "management", "groups,", "private", "health", "or", "science", "foundations", "and", "organizations", "involved", "in", "various", "diseases", "from", "time", "to", "time", "publish", "guidelines", "or", "recommendations", "to", "the", "medical", "and", "patient", "communities.", "<tag2>", "We", "filed", "a", "universal", "shelf", "registration", "statement", "with", "the", "SEC", "on", "Form", "S-3", "(File", "No.", "333-179043)", "on", "January", "17,", "2012,", "which", "was", "declared", "effective", "on", "January", "24,", "2012,", "for", "the", "proposed", "offering", "from", "time", "to", "time", "of", "up", "to", "$100.0", "million", "of", "our", "securities,", "including", "common", "stock,", "preferred", "stock,", "debt", "securities", "and/or", "warrants.", "<tag3>"], "wordsA": ["In", "addition,", "professional", "societies,", "practice", "management", "groups,", "private", "health", "or", "science", "foundations", "and", "organizations", "involved", "in", "various", "diseases", "from", "time", "to", "time", "publish", "guidelines", "or", "recommendations", "to", "the", "medical", "and", "patient", "communities."], "wordsB": ["We", "filed", "a", "universal", "shelf", "registration", "statement", "with", "the", "SEC", "on", "Form", "S-3", "(File", "No.", "333-179043)", "on", "January", "17,", "2012,", "which", "was", "declared", "effective", "on", "January", "24,", "2012,", "for", "the", "proposed", "offering", "from", "time", "to", "time", "of", "up", "to", "$100.0", "million", "of", "our", "securities,", "including", "common", "stock,", "preferred", "stock,", "debt", "securities", "and/or", "warrants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item1a_p108_s0", "idA": "1316175_11_item1a_p131_s0", "sentA": "property infringement related to our product candidates, the pharmaceutical industry is characterized by extensive litigation regarding patents and other intellectual property rights.", "sentB": "We are aware of two families of third party United States patents and pending foreign applications that contain broad claims related to BLyS or BAFF binding polypeptides.", "type": 1, "words": ["<tag1>", "property", "infringement", "related", "to", "our", "product", "candidates,", "the", "pharmaceutical", "industry", "is", "characterized", "by", "extensive", "litigation", "regarding", "patents", "and", "other", "intellectual", "property", "rights.", "<tag2>", "We", "are", "aware", "of", "two", "families", "of", "third", "party", "United", "States", "patents", "and", "pending", "foreign", "applications", "that", "contain", "broad", "claims", "related", "to", "BLyS", "or", "BAFF", "binding", "polypeptides.", "<tag3>"], "wordsA": ["property", "infringement", "related", "to", "our", "product", "candidates,", "the", "pharmaceutical", "industry", "is", "characterized", "by", "extensive", "litigation", "regarding", "patents", "and", "other", "intellectual", "property", "rights."], "wordsB": ["We", "are", "aware", "of", "two", "families", "of", "third", "party", "United", "States", "patents", "and", "pending", "foreign", "applications", "that", "contain", "broad", "claims", "related", "to", "BLyS", "or", "BAFF", "binding", "polypeptides."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item1a_p93_s0", "idA": "1316175_11_item1a_p17_s2", "sentA": "For varespladib, we are required to pay up to $32.0 million upon achievement of certain approval and post-approval sales milestones.", "sentB": "In December 2011, we completed the technology transfer from Amgen and manufacturing scale up to 3,000 liters at our contract manufacturing organization, or CRO (Fujifilm Diosynth Bioservices or \"Fujifilm\").", "type": 1, "words": ["<tag1>", "For", "varespladib,", "we", "are", "required", "to", "pay", "up", "to", "$32.0", "million", "upon", "achievement", "of", "certain", "approval", "and", "post-approval", "sales", "milestones.", "<tag2>", "In", "December", "2011,", "we", "completed", "the", "technology", "transfer", "from", "Amgen", "and", "manufacturing", "scale", "up", "to", "3,000", "liters", "at", "our", "contract", "manufacturing", "organization,", "or", "CRO", "(Fujifilm", "Diosynth", "Bioservices", "or", "\"Fujifilm\").", "<tag3>"], "wordsA": ["For", "varespladib,", "we", "are", "required", "to", "pay", "up", "to", "$32.0", "million", "upon", "achievement", "of", "certain", "approval", "and", "post-approval", "sales", "milestones."], "wordsB": ["In", "December", "2011,", "we", "completed", "the", "technology", "transfer", "from", "Amgen", "and", "manufacturing", "scale", "up", "to", "3,000", "liters", "at", "our", "contract", "manufacturing", "organization,", "or", "CRO", "(Fujifilm", "Diosynth", "Bioservices", "or", "\"Fujifilm\")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item1a_p26_s0", "idA": "1316175_11_item1a_p88_s1", "sentA": "We could be held liable for any contamination, injury or other damages resulting from these hazardous substances.", "sentB": "offer therapeutic or other improvement over existing, comparable therapeutics; be proven safe and effective in clinical studies; meet applicable regulatory standards; be capable of being produced in sufficient quantities at acceptable costs; be successfully commercialized; or obtain favorable reimbursement.", "type": 1, "words": ["<tag1>", "We", "could", "be", "held", "liable", "for", "any", "contamination,", "injury", "or", "other", "damages", "resulting", "from", "these", "hazardous", "substances.", "<tag2>", "offer", "therapeutic", "or", "other", "improvement", "over", "existing,", "comparable", "therapeutics;", "be", "proven", "safe", "and", "effective", "in", "clinical", "studies;", "meet", "applicable", "regulatory", "standards;", "be", "capable", "of", "being", "produced", "in", "sufficient", "quantities", "at", "acceptable", "costs;", "be", "successfully", "commercialized;", "or", "obtain", "favorable", "reimbursement.", "<tag3>"], "wordsA": ["We", "could", "be", "held", "liable", "for", "any", "contamination,", "injury", "or", "other", "damages", "resulting", "from", "these", "hazardous", "substances."], "wordsB": ["offer", "therapeutic", "or", "other", "improvement", "over", "existing,", "comparable", "therapeutics;", "be", "proven", "safe", "and", "effective", "in", "clinical", "studies;", "meet", "applicable", "regulatory", "standards;", "be", "capable", "of", "being", "produced", "in", "sufficient", "quantities", "at", "acceptable", "costs;", "be", "successfully", "commercialized;", "or", "obtain", "favorable", "reimbursement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item1a_p93_s1", "idA": "1316175_11_item1a_p98_s2", "sentA": "Such suppliers may not sell these raw materials to our manufacturers at the times we need them or on commercially reasonable terms.", "sentB": "Two (2) batches of blisibimod produced under US FDA good manufacturing procedures, or GMP, at the 3,000 liter scale passed all physical quality specifications and comparability assessments.", "type": 1, "words": ["<tag1>", "Such", "suppliers", "may", "not", "sell", "these", "raw", "materials", "to", "our", "manufacturers", "at", "the", "times", "we", "need", "them", "or", "on", "commercially", "reasonable", "terms.", "<tag2>", "Two", "(2)", "batches", "of", "blisibimod", "produced", "under", "US", "FDA", "good", "manufacturing", "procedures,", "or", "GMP,", "at", "the", "3,000", "liter", "scale", "passed", "all", "physical", "quality", "specifications", "and", "comparability", "assessments.", "<tag3>"], "wordsA": ["Such", "suppliers", "may", "not", "sell", "these", "raw", "materials", "to", "our", "manufacturers", "at", "the", "times", "we", "need", "them", "or", "on", "commercially", "reasonable", "terms."], "wordsB": ["Two", "(2)", "batches", "of", "blisibimod", "produced", "under", "US", "FDA", "good", "manufacturing", "procedures,", "or", "GMP,", "at", "the", "3,000", "liter", "scale", "passed", "all", "physical", "quality", "specifications", "and", "comparability", "assessments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p46_s6", "idA": "1316175_12_item1a_p12_s0", "sentA": "revenues received from approved products, if any, in the future.", "sentB": "There were more cardiovascular events in the varespladib arm of this study versus the placebo (117 versus 95, p=0.113).", "type": 1, "words": ["<tag1>", "revenues", "received", "from", "approved", "products,", "if", "any,", "in", "the", "future.", "<tag2>", "There", "were", "more", "cardiovascular", "events", "in", "the", "varespladib", "arm", "of", "this", "study", "versus", "the", "placebo", "(117", "versus", "95,", "p=0.113).", "<tag3>"], "wordsA": ["revenues", "received", "from", "approved", "products,", "if", "any,", "in", "the", "future."], "wordsB": ["There", "were", "more", "cardiovascular", "events", "in", "the", "varespladib", "arm", "of", "this", "study", "versus", "the", "placebo", "(117", "versus", "95,", "p=0.113)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p124_s2", "idA": "1316175_12_item1a_p133_s1", "sentA": "Investor trading patterns could serve to exacerbate the volatility of the price of the stock.", "sentB": "These requirements include maintaining a minimum closing bid price of $1.00 per share.", "type": 1, "words": ["<tag1>", "Investor", "trading", "patterns", "could", "serve", "to", "exacerbate", "the", "volatility", "of", "the", "price", "of", "the", "stock.", "<tag2>", "These", "requirements", "include", "maintaining", "a", "minimum", "closing", "bid", "price", "of", "$1.00", "per", "share.", "<tag3>"], "wordsA": ["Investor", "trading", "patterns", "could", "serve", "to", "exacerbate", "the", "volatility", "of", "the", "price", "of", "the", "stock."], "wordsB": ["These", "requirements", "include", "maintaining", "a", "minimum", "closing", "bid", "price", "of", "$1.00", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p124_s1", "idA": "1316175_12_item1a_p134_s0", "sentA": "In the past, securities class action litigation has often been brought against a company after a period of volatility in the market price of its common stock.", "sentB": "NASDAQ has minimum requirements that a company must meet in order to remain listed on NASDAQ.", "type": 1, "words": ["<tag1>", "In", "the", "past,", "securities", "class", "action", "litigation", "has", "often", "been", "brought", "against", "a", "company", "after", "a", "period", "of", "volatility", "in", "the", "market", "price", "of", "its", "common", "stock.", "<tag2>", "NASDAQ", "has", "minimum", "requirements", "that", "a", "company", "must", "meet", "in", "order", "to", "remain", "listed", "on", "NASDAQ.", "<tag3>"], "wordsA": ["In", "the", "past,", "securities", "class", "action", "litigation", "has", "often", "been", "brought", "against", "a", "company", "after", "a", "period", "of", "volatility", "in", "the", "market", "price", "of", "its", "common", "stock."], "wordsB": ["NASDAQ", "has", "minimum", "requirements", "that", "a", "company", "must", "meet", "in", "order", "to", "remain", "listed", "on", "NASDAQ."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p125_s1", "idA": "1316175_12_item1a_p134_s0", "sentA": "In the past, securities class action litigation has often been brought against a company after a period of volatility in the market price of its common stock.", "sentB": "The letter stated that Nasdaq will provide the Company a grace period of 180 calendar days, or until June 18, 2013, to regain compliance.", "type": 1, "words": ["<tag1>", "In", "the", "past,", "securities", "class", "action", "litigation", "has", "often", "been", "brought", "against", "a", "company", "after", "a", "period", "of", "volatility", "in", "the", "market", "price", "of", "its", "common", "stock.", "<tag2>", "The", "letter", "stated", "that", "Nasdaq", "will", "provide", "the", "Company", "a", "grace", "period", "of", "180", "calendar", "days,", "or", "until", "June", "18,", "2013,", "to", "regain", "compliance.", "<tag3>"], "wordsA": ["In", "the", "past,", "securities", "class", "action", "litigation", "has", "often", "been", "brought", "against", "a", "company", "after", "a", "period", "of", "volatility", "in", "the", "market", "price", "of", "its", "common", "stock."], "wordsB": ["The", "letter", "stated", "that", "Nasdaq", "will", "provide", "the", "Company", "a", "grace", "period", "of", "180", "calendar", "days,", "or", "until", "June", "18,", "2013,", "to", "regain", "compliance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p138_s1", "idA": "1316175_12_item1a_p144_s0", "sentA": "Operating as a public company increases our expenses and administrative burden.", "sentB": "In January 2013, we issued 60,606,061 shares at an initial closing of a public offering, followed by a second closing of 9,090,909 shares in February 2013.", "type": 1, "words": ["<tag1>", "Operating", "as", "a", "public", "company", "increases", "our", "expenses", "and", "administrative", "burden.", "<tag2>", "In", "January", "2013,", "we", "issued", "60,606,061", "shares", "at", "an", "initial", "closing", "of", "a", "public", "offering,", "followed", "by", "a", "second", "closing", "of", "9,090,909", "shares", "in", "February", "2013.", "<tag3>"], "wordsA": ["Operating", "as", "a", "public", "company", "increases", "our", "expenses", "and", "administrative", "burden."], "wordsB": ["In", "January", "2013,", "we", "issued", "60,606,061", "shares", "at", "an", "initial", "closing", "of", "a", "public", "offering,", "followed", "by", "a", "second", "closing", "of", "9,090,909", "shares", "in", "February", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p24_s1", "idA": "1316175_12_item1a_p15_s0", "sentA": "The timing of the milestone and royalty payments we are required to make to each of Eli Lilly and Company, Shionogi Co., Ltd. and Amgen Inc. is uncertain and could adversely affect our cash flows and results of operations.", "sentB": "The trial was completed and results were announced during 2012.", "type": 1, "words": ["<tag1>", "The", "timing", "of", "the", "milestone", "and", "royalty", "payments", "we", "are", "required", "to", "make", "to", "each", "of", "Eli", "Lilly", "and", "Company,", "Shionogi", "Co.,", "Ltd.", "and", "Amgen", "Inc.", "is", "uncertain", "and", "could", "adversely", "affect", "our", "cash", "flows", "and", "results", "of", "operations.", "<tag2>", "The", "trial", "was", "completed", "and", "results", "were", "announced", "during", "2012.", "<tag3>"], "wordsA": ["The", "timing", "of", "the", "milestone", "and", "royalty", "payments", "we", "are", "required", "to", "make", "to", "each", "of", "Eli", "Lilly", "and", "Company,", "Shionogi", "Co.,", "Ltd.", "and", "Amgen", "Inc.", "is", "uncertain", "and", "could", "adversely", "affect", "our", "cash", "flows", "and", "results", "of", "operations."], "wordsB": ["The", "trial", "was", "completed", "and", "results", "were", "announced", "during", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p141_s0", "idA": "1316175_12_item1a_p17_s0", "sentA": "In addition, in December 2007, we entered into a license agreement with Amgen Inc., or Amgen, pursuant to which we obtained an exclusive worldwide license to certain technology and compounds relating to blisibimod.", "sentB": "On November 8, 2012, we entered into an At Market Issuance Sales Agreement (the Agreement ) with MLV Co.", "type": 1, "words": ["<tag1>", "In", "addition,", "in", "December", "2007,", "we", "entered", "into", "a", "license", "agreement", "with", "Amgen", "Inc.,", "or", "Amgen,", "pursuant", "to", "which", "we", "obtained", "an", "exclusive", "worldwide", "license", "to", "certain", "technology", "and", "compounds", "relating", "to", "blisibimod.", "<tag2>", "On", "November", "8,", "2012,", "we", "entered", "into", "an", "At", "Market", "Issuance", "Sales", "Agreement", "(the", "Agreement", ")", "with", "MLV", "Co.", "<tag3>"], "wordsA": ["In", "addition,", "in", "December", "2007,", "we", "entered", "into", "a", "license", "agreement", "with", "Amgen", "Inc.,", "or", "Amgen,", "pursuant", "to", "which", "we", "obtained", "an", "exclusive", "worldwide", "license", "to", "certain", "technology", "and", "compounds", "relating", "to", "blisibimod."], "wordsB": ["On", "November", "8,", "2012,", "we", "entered", "into", "an", "At", "Market", "Issuance", "Sales", "Agreement", "(the", "Agreement", ")", "with", "MLV", "Co."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p106_s3", "idA": "1316175_12_item1a_p17_s1", "sentA": "Pursuant to our license agreement with Amgen, we are required to make various milestone payments upon our achievement of certain development, regulatory and commercial objectives for any blisibimod formulation.", "sentB": "The license agreement was effectively terminated in November 2012.", "type": 1, "words": ["<tag1>", "Pursuant", "to", "our", "license", "agreement", "with", "Amgen,", "we", "are", "required", "to", "make", "various", "milestone", "payments", "upon", "our", "achievement", "of", "certain", "development,", "regulatory", "and", "commercial", "objectives", "for", "any", "blisibimod", "formulation.", "<tag2>", "The", "license", "agreement", "was", "effectively", "terminated", "in", "November", "2012.", "<tag3>"], "wordsA": ["Pursuant", "to", "our", "license", "agreement", "with", "Amgen,", "we", "are", "required", "to", "make", "various", "milestone", "payments", "upon", "our", "achievement", "of", "certain", "development,", "regulatory", "and", "commercial", "objectives", "for", "any", "blisibimod", "formulation."], "wordsB": ["The", "license", "agreement", "was", "effectively", "terminated", "in", "November", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p95_s4", "idA": "1316175_12_item1a_p17_s1", "sentA": "Pursuant to our license agreement with Amgen, we are required to make various milestone payments upon our achievement of certain development, regulatory and commercial objectives for any blisibimod formulation.", "sentB": "The license agreement was effectively terminated in November 2012.", "type": 1, "words": ["<tag1>", "Pursuant", "to", "our", "license", "agreement", "with", "Amgen,", "we", "are", "required", "to", "make", "various", "milestone", "payments", "upon", "our", "achievement", "of", "certain", "development,", "regulatory", "and", "commercial", "objectives", "for", "any", "blisibimod", "formulation.", "<tag2>", "The", "license", "agreement", "was", "effectively", "terminated", "in", "November", "2012.", "<tag3>"], "wordsA": ["Pursuant", "to", "our", "license", "agreement", "with", "Amgen,", "we", "are", "required", "to", "make", "various", "milestone", "payments", "upon", "our", "achievement", "of", "certain", "development,", "regulatory", "and", "commercial", "objectives", "for", "any", "blisibimod", "formulation."], "wordsB": ["The", "license", "agreement", "was", "effectively", "terminated", "in", "November", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p128_s0", "idA": "1316175_12_item1a_p53_s1", "sentA": "We cannot assure you that the regulatory agencies will complete their review processes in a timely manner or that we will obtain regulatory approval for any product candidate we develop.", "sentB": "obtain a signed and dated acknowledgement from the purchaser demonstrating that the purchaser has actually received the required risk disclosure document before a transaction in a penny stock can be completed.", "type": 1, "words": ["<tag1>", "We", "cannot", "assure", "you", "that", "the", "regulatory", "agencies", "will", "complete", "their", "review", "processes", "in", "a", "timely", "manner", "or", "that", "we", "will", "obtain", "regulatory", "approval", "for", "any", "product", "candidate", "we", "develop.", "<tag2>", "obtain", "a", "signed", "and", "dated", "acknowledgement", "from", "the", "purchaser", "demonstrating", "that", "the", "purchaser", "has", "actually", "received", "the", "required", "risk", "disclosure", "document", "before", "a", "transaction", "in", "a", "penny", "stock", "can", "be", "completed.", "<tag3>"], "wordsA": ["We", "cannot", "assure", "you", "that", "the", "regulatory", "agencies", "will", "complete", "their", "review", "processes", "in", "a", "timely", "manner", "or", "that", "we", "will", "obtain", "regulatory", "approval", "for", "any", "product", "candidate", "we", "develop."], "wordsB": ["obtain", "a", "signed", "and", "dated", "acknowledgement", "from", "the", "purchaser", "demonstrating", "that", "the", "purchaser", "has", "actually", "received", "the", "required", "risk", "disclosure", "document", "before", "a", "transaction", "in", "a", "penny", "stock", "can", "be", "completed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p141_s3", "idA": "1316175_12_item1a_p56_s1", "sentA": "For example, the label ultimately approved for varespladib, if any, may include restrictions on use.", "sentB": "This facility is no longer available for use.", "type": 1, "words": ["<tag1>", "For", "example,", "the", "label", "ultimately", "approved", "for", "varespladib,", "if", "any,", "may", "include", "restrictions", "on", "use.", "<tag2>", "This", "facility", "is", "no", "longer", "available", "for", "use.", "<tag3>"], "wordsA": ["For", "example,", "the", "label", "ultimately", "approved", "for", "varespladib,", "if", "any,", "may", "include", "restrictions", "on", "use."], "wordsB": ["This", "facility", "is", "no", "longer", "available", "for", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p46_s7", "idA": "1316175_12_item1a_p58_s0", "sentA": "The occurrence of any event or penalty described above may inhibit our ability to commercialize our products and generate revenue.", "sentB": "This finding was driven by a significantly higher occurrence of non-fatal myocardial infarction in those patients treated with varespladib compared to those treated with placebo.", "type": 1, "words": ["<tag1>", "The", "occurrence", "of", "any", "event", "or", "penalty", "described", "above", "may", "inhibit", "our", "ability", "to", "commercialize", "our", "products", "and", "generate", "revenue.", "<tag2>", "This", "finding", "was", "driven", "by", "a", "significantly", "higher", "occurrence", "of", "non-fatal", "myocardial", "infarction", "in", "those", "patients", "treated", "with", "varespladib", "compared", "to", "those", "treated", "with", "placebo.", "<tag3>"], "wordsA": ["The", "occurrence", "of", "any", "event", "or", "penalty", "described", "above", "may", "inhibit", "our", "ability", "to", "commercialize", "our", "products", "and", "generate", "revenue."], "wordsB": ["This", "finding", "was", "driven", "by", "a", "significantly", "higher", "occurrence", "of", "non-fatal", "myocardial", "infarction", "in", "those", "patients", "treated", "with", "varespladib", "compared", "to", "those", "treated", "with", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p127_s2", "idA": "1316175_12_item1a_p66_s7", "sentA": "Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us.", "sentB": "Under these rules, broker-dealers who recommend such securities to persons other than institutional accredited investors must:", "type": 1, "words": ["<tag1>", "Our", "consultants", "and", "advisors", "may", "be", "employed", "by", "employers", "other", "than", "us", "and", "may", "have", "commitments", "under", "consulting", "or", "advisory", "contracts", "with", "other", "entities", "that", "may", "limit", "their", "availability", "to", "us.", "<tag2>", "Under", "these", "rules,", "broker-dealers", "who", "recommend", "such", "securities", "to", "persons", "other", "than", "institutional", "accredited", "investors", "must:", "<tag3>"], "wordsA": ["Our", "consultants", "and", "advisors", "may", "be", "employed", "by", "employers", "other", "than", "us", "and", "may", "have", "commitments", "under", "consulting", "or", "advisory", "contracts", "with", "other", "entities", "that", "may", "limit", "their", "availability", "to", "us."], "wordsB": ["Under", "these", "rules,", "broker-dealers", "who", "recommend", "such", "securities", "to", "persons", "other", "than", "institutional", "accredited", "investors", "must:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item1a_p126_s1", "idA": "1316175_12_item1a_p92_s1", "sentA": "In addition, the FDA and other regulatory authorities require that our product candidates be manufactured according to cGMP and similar foreign standards.", "sentB": "In addition, if delisted we would no longer be subject to NASDAQ rules, including rules requiring us to have a certain number of independent directors and to meet other corporate governance standards.", "type": 1, "words": ["<tag1>", "In", "addition,", "the", "FDA", "and", "other", "regulatory", "authorities", "require", "that", "our", "product", "candidates", "be", "manufactured", "according", "to", "cGMP", "and", "similar", "foreign", "standards.", "<tag2>", "In", "addition,", "if", "delisted", "we", "would", "no", "longer", "be", "subject", "to", "NASDAQ", "rules,", "including", "rules", "requiring", "us", "to", "have", "a", "certain", "number", "of", "independent", "directors", "and", "to", "meet", "other", "corporate", "governance", "standards.", "<tag3>"], "wordsA": ["In", "addition,", "the", "FDA", "and", "other", "regulatory", "authorities", "require", "that", "our", "product", "candidates", "be", "manufactured", "according", "to", "cGMP", "and", "similar", "foreign", "standards."], "wordsB": ["In", "addition,", "if", "delisted", "we", "would", "no", "longer", "be", "subject", "to", "NASDAQ", "rules,", "including", "rules", "requiring", "us", "to", "have", "a", "certain", "number", "of", "independent", "directors", "and", "to", "meet", "other", "corporate", "governance", "standards."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item1a_p46_s5", "idA": "1316175_13_item1a_p146_s0", "sentA": "As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company.", "sentB": "Amongst the commonly-reported AEs, imbalance was observed only with injection site reactions (200mg QW blisibimod = 15%, matched placebo = 7%), but these were not serious or severe and did not result in discontinuation of treatment.", "type": 1, "words": ["<tag1>", "As", "a", "public", "company,", "we", "incur", "significant", "legal,", "accounting", "and", "other", "expenses", "that", "we", "did", "not", "incur", "as", "a", "private", "company.", "<tag2>", "Amongst", "the", "commonly-reported", "AEs,", "imbalance", "was", "observed", "only", "with", "injection", "site", "reactions", "(200mg", "QW", "blisibimod", "=", "15%,", "matched", "placebo", "=", "7%),", "but", "these", "were", "not", "serious", "or", "severe", "and", "did", "not", "result", "in", "discontinuation", "of", "treatment.", "<tag3>"], "wordsA": ["As", "a", "public", "company,", "we", "incur", "significant", "legal,", "accounting", "and", "other", "expenses", "that", "we", "did", "not", "incur", "as", "a", "private", "company."], "wordsB": ["Amongst", "the", "commonly-reported", "AEs,", "imbalance", "was", "observed", "only", "with", "injection", "site", "reactions", "(200mg", "QW", "blisibimod", "=", "15%,", "matched", "placebo", "=", "7%),", "but", "these", "were", "not", "serious", "or", "severe", "and", "did", "not", "result", "in", "discontinuation", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item1a_p140_s2", "idA": "1316175_13_item1a_p146_s1", "sentA": "In addition, our administrative staff will be required to perform additional tasks.", "sentB": "A control can provide only reasonable, not absolute, assurance that the objectives of the control system will be attained.", "type": 1, "words": ["<tag1>", "In", "addition,", "our", "administrative", "staff", "will", "be", "required", "to", "perform", "additional", "tasks.", "<tag2>", "A", "control", "can", "provide", "only", "reasonable,", "not", "absolute,", "assurance", "that", "the", "objectives", "of", "the", "control", "system", "will", "be", "attained.", "<tag3>"], "wordsA": ["In", "addition,", "our", "administrative", "staff", "will", "be", "required", "to", "perform", "additional", "tasks."], "wordsB": ["A", "control", "can", "provide", "only", "reasonable,", "not", "absolute,", "assurance", "that", "the", "objectives", "of", "the", "control", "system", "will", "be", "attained."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item1a_p46_s4", "idA": "1316175_13_item1a_p23_s2", "sentA": "In November 2010, we placed a voluntary hold on the PEARL-SC study due to problems found with vials.", "sentB": "Discontinuation due to adverse event was slower amongst blisibimod-treated subjects (5.7%) compared to placebo (7.9%).", "type": 1, "words": ["<tag1>", "In", "November", "2010,", "we", "placed", "a", "voluntary", "hold", "on", "the", "PEARL-SC", "study", "due", "to", "problems", "found", "with", "vials.", "<tag2>", "Discontinuation", "due", "to", "adverse", "event", "was", "slower", "amongst", "blisibimod-treated", "subjects", "(5.7%)", "compared", "to", "placebo", "(7.9%).", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "placed", "a", "voluntary", "hold", "on", "the", "PEARL-SC", "study", "due", "to", "problems", "found", "with", "vials."], "wordsB": ["Discontinuation", "due", "to", "adverse", "event", "was", "slower", "amongst", "blisibimod-treated", "subjects", "(5.7%)", "compared", "to", "placebo", "(7.9%)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item1a_p87_s0", "idA": "1316175_13_item1a_p86_s1", "sentA": "Two (2) batches of blisibimod produced under FDA good manufacturing procedures, or GMP, at the 3,000 liter scale passed all physical quality specifications and comparability assessments.", "sentB": "The Company initiated activities for large scale purification of its next batch of blisibimod with its contract manufacturer.", "type": 1, "words": ["<tag1>", "Two", "(2)", "batches", "of", "blisibimod", "produced", "under", "FDA", "good", "manufacturing", "procedures,", "or", "GMP,", "at", "the", "3,000", "liter", "scale", "passed", "all", "physical", "quality", "specifications", "and", "comparability", "assessments.", "<tag2>", "The", "Company", "initiated", "activities", "for", "large", "scale", "purification", "of", "its", "next", "batch", "of", "blisibimod", "with", "its", "contract", "manufacturer.", "<tag3>"], "wordsA": ["Two", "(2)", "batches", "of", "blisibimod", "produced", "under", "FDA", "good", "manufacturing", "procedures,", "or", "GMP,", "at", "the", "3,000", "liter", "scale", "passed", "all", "physical", "quality", "specifications", "and", "comparability", "assessments."], "wordsB": ["The", "Company", "initiated", "activities", "for", "large", "scale", "purification", "of", "its", "next", "batch", "of", "blisibimod", "with", "its", "contract", "manufacturer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item1a_p87_s1", "idA": "1316175_13_item1a_p88_s2", "sentA": "In addition, as our drug development pipeline increases and matures, we will have a greater need for clinical study and commercial manufacturing capacity.", "sentB": "It is anticipated that final product from this product manufacturing campaign will provide sufficient CAHBLIS-SC1 clinical study and the initiation of the second pivotal study in patients with lupus.", "type": 1, "words": ["<tag1>", "In", "addition,", "as", "our", "drug", "development", "pipeline", "increases", "and", "matures,", "we", "will", "have", "a", "greater", "need", "for", "clinical", "study", "and", "commercial", "manufacturing", "capacity.", "<tag2>", "It", "is", "anticipated", "that", "final", "product", "from", "this", "product", "manufacturing", "campaign", "will", "provide", "sufficient", "CAHBLIS-SC1", "clinical", "study", "and", "the", "initiation", "of", "the", "second", "pivotal", "study", "in", "patients", "with", "lupus.", "<tag3>"], "wordsA": ["In", "addition,", "as", "our", "drug", "development", "pipeline", "increases", "and", "matures,", "we", "will", "have", "a", "greater", "need", "for", "clinical", "study", "and", "commercial", "manufacturing", "capacity."], "wordsB": ["It", "is", "anticipated", "that", "final", "product", "from", "this", "product", "manufacturing", "campaign", "will", "provide", "sufficient", "CAHBLIS-SC1", "clinical", "study", "and", "the", "initiation", "of", "the", "second", "pivotal", "study", "in", "patients", "with", "lupus."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p19_s0", "idA": "1316175_14_item1a_p120_s1", "sentA": "Although we are not currently aware of any litigation or other proceedings or third-party claims of intellectual property infringement related to our product candidate, the pharmaceutical industry is characterized by extensive litigation regarding patents and other intellectual property rights.", "sentB": "place us at a competitive disadvantage when compared to our competitors who are not similarly restricted.", "type": 1, "words": ["<tag1>", "Although", "we", "are", "not", "currently", "aware", "of", "any", "litigation", "or", "other", "proceedings", "or", "third-party", "claims", "of", "intellectual", "property", "infringement", "related", "to", "our", "product", "candidate,", "the", "pharmaceutical", "industry", "is", "characterized", "by", "extensive", "litigation", "regarding", "patents", "and", "other", "intellectual", "property", "rights.", "<tag2>", "place", "us", "at", "a", "competitive", "disadvantage", "when", "compared", "to", "our", "competitors", "who", "are", "not", "similarly", "restricted.", "<tag3>"], "wordsA": ["Although", "we", "are", "not", "currently", "aware", "of", "any", "litigation", "or", "other", "proceedings", "or", "third-party", "claims", "of", "intellectual", "property", "infringement", "related", "to", "our", "product", "candidate,", "the", "pharmaceutical", "industry", "is", "characterized", "by", "extensive", "litigation", "regarding", "patents", "and", "other", "intellectual", "property", "rights."], "wordsB": ["place", "us", "at", "a", "competitive", "disadvantage", "when", "compared", "to", "our", "competitors", "who", "are", "not", "similarly", "restricted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p18_s1", "idA": "1316175_14_item1a_p145_s2", "sentA": "Any return to stockholders will therefore be limited to the value of their stock.", "sentB": "In connection with these credit agreements, our debt obligations to the lenders could:", "type": 1, "words": ["<tag1>", "Any", "return", "to", "stockholders", "will", "therefore", "be", "limited", "to", "the", "value", "of", "their", "stock.", "<tag2>", "In", "connection", "with", "these", "credit", "agreements,", "our", "debt", "obligations", "to", "the", "lenders", "could:", "<tag3>"], "wordsA": ["Any", "return", "to", "stockholders", "will", "therefore", "be", "limited", "to", "the", "value", "of", "their", "stock."], "wordsB": ["In", "connection", "with", "these", "credit", "agreements,", "our", "debt", "obligations", "to", "the", "lenders", "could:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p41_s2", "idA": "1316175_14_item1a_p149_s2", "sentA": "In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management.", "sentB": "Under the collaborative arrangement, Zenyaku is responsible for:", "type": 1, "words": ["<tag1>", "In", "addition,", "these", "provisions", "may", "frustrate", "or", "prevent", "any", "attempts", "by", "our", "stockholders", "to", "replace", "or", "remove", "our", "current", "management", "by", "making", "it", "more", "difficult", "for", "stockholders", "to", "replace", "members", "of", "our", "board", "of", "directors,", "which", "is", "responsible", "for", "appointing", "the", "members", "of", "our", "management.", "<tag2>", "Under", "the", "collaborative", "arrangement,", "Zenyaku", "is", "responsible", "for:", "<tag3>"], "wordsA": ["In", "addition,", "these", "provisions", "may", "frustrate", "or", "prevent", "any", "attempts", "by", "our", "stockholders", "to", "replace", "or", "remove", "our", "current", "management", "by", "making", "it", "more", "difficult", "for", "stockholders", "to", "replace", "members", "of", "our", "board", "of", "directors,", "which", "is", "responsible", "for", "appointing", "the", "members", "of", "our", "management."], "wordsB": ["Under", "the", "collaborative", "arrangement,", "Zenyaku", "is", "responsible", "for:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p29_s1", "idA": "1316175_14_item1a_p34_s1", "sentA": "Amendments may require us to resubmit our clinical study protocols to IRBs for reexamination, which may impact the costs, timing or successful completion of a clinical study.", "sentB": "We may receive informal verbal and or written guidance from these authority agencies which may help form the basis of our clinical trial designs.", "type": 1, "words": ["<tag1>", "Amendments", "may", "require", "us", "to", "resubmit", "our", "clinical", "study", "protocols", "to", "IRBs", "for", "reexamination,", "which", "may", "impact", "the", "costs,", "timing", "or", "successful", "completion", "of", "a", "clinical", "study.", "<tag2>", "We", "may", "receive", "informal", "verbal", "and", "or", "written", "guidance", "from", "these", "authority", "agencies", "which", "may", "help", "form", "the", "basis", "of", "our", "clinical", "trial", "designs.", "<tag3>"], "wordsA": ["Amendments", "may", "require", "us", "to", "resubmit", "our", "clinical", "study", "protocols", "to", "IRBs", "for", "reexamination,", "which", "may", "impact", "the", "costs,", "timing", "or", "successful", "completion", "of", "a", "clinical", "study."], "wordsB": ["We", "may", "receive", "informal", "verbal", "and", "or", "written", "guidance", "from", "these", "authority", "agencies", "which", "may", "help", "form", "the", "basis", "of", "our", "clinical", "trial", "designs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p41_s0", "idA": "1316175_14_item1a_p44_s2", "sentA": "Our competitors drugs may be more effective, have fewer adverse effects, be less expensive to develop and manufacture or be more effectively marketed and sold than any product candidate we may commercialize and may render our product candidate obsolete or non-competitive before we can recover the expenses of developing and commercializing our product candidate.", "sentB": "Our strategy for fully developing and commercializing our products is dependent upon maintaining our current arrangements and establishing new arrangements with research collaborators, corporate collaborators and others.", "type": 1, "words": ["<tag1>", "Our", "competitors", "drugs", "may", "be", "more", "effective,", "have", "fewer", "adverse", "effects,", "be", "less", "expensive", "to", "develop", "and", "manufacture", "or", "be", "more", "effectively", "marketed", "and", "sold", "than", "any", "product", "candidate", "we", "may", "commercialize", "and", "may", "render", "our", "product", "candidate", "obsolete", "or", "non-competitive", "before", "we", "can", "recover", "the", "expenses", "of", "developing", "and", "commercializing", "our", "product", "candidate.", "<tag2>", "Our", "strategy", "for", "fully", "developing", "and", "commercializing", "our", "products", "is", "dependent", "upon", "maintaining", "our", "current", "arrangements", "and", "establishing", "new", "arrangements", "with", "research", "collaborators,", "corporate", "collaborators", "and", "others.", "<tag3>"], "wordsA": ["Our", "competitors", "drugs", "may", "be", "more", "effective,", "have", "fewer", "adverse", "effects,", "be", "less", "expensive", "to", "develop", "and", "manufacture", "or", "be", "more", "effectively", "marketed", "and", "sold", "than", "any", "product", "candidate", "we", "may", "commercialize", "and", "may", "render", "our", "product", "candidate", "obsolete", "or", "non-competitive", "before", "we", "can", "recover", "the", "expenses", "of", "developing", "and", "commercializing", "our", "product", "candidate."], "wordsB": ["Our", "strategy", "for", "fully", "developing", "and", "commercializing", "our", "products", "is", "dependent", "upon", "maintaining", "our", "current", "arrangements", "and", "establishing", "new", "arrangements", "with", "research", "collaborators,", "corporate", "collaborators", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p56_s7", "idA": "1316175_14_item1a_p46_s1", "sentA": "Phase 2 clinical studies conducted by us with our product candidate have generated differences in adverse effects and serious adverse events.", "sentB": "Studies conducted by our licensor on liprotamase have generated the following common adverse effects: general gastrointestinal disorder, such as abdominal pain, flatulence, loose stools and diarrhea.", "type": 1, "words": ["<tag1>", "Phase", "2", "clinical", "studies", "conducted", "by", "us", "with", "our", "product", "candidate", "have", "generated", "differences", "in", "adverse", "effects", "and", "serious", "adverse", "events.", "<tag2>", "Studies", "conducted", "by", "our", "licensor", "on", "liprotamase", "have", "generated", "the", "following", "common", "adverse", "effects:", "general", "gastrointestinal", "disorder,", "such", "as", "abdominal", "pain,", "flatulence,", "loose", "stools", "and", "diarrhea.", "<tag3>"], "wordsA": ["Phase", "2", "clinical", "studies", "conducted", "by", "us", "with", "our", "product", "candidate", "have", "generated", "differences", "in", "adverse", "effects", "and", "serious", "adverse", "events."], "wordsB": ["Studies", "conducted", "by", "our", "licensor", "on", "liprotamase", "have", "generated", "the", "following", "common", "adverse", "effects:", "general", "gastrointestinal", "disorder,", "such", "as", "abdominal", "pain,", "flatulence,", "loose", "stools", "and", "diarrhea."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p53_s1", "idA": "1316175_14_item1a_p88_s1", "sentA": "There are a small number of suppliers for certain capital equipment and raw materials that we use to manufacture our drugs.", "sentB": "There are currently several marketed products for EPI caused by cystic fibrosis, including Creon marketed by AbbVie, Inc., Pancreaze by Janssen Pharmaceuticals, Inc., Pertzye by Cornestone Therapeutics, Inc., and Ultresa and Zenpep by Aptalis Pharma US.", "type": 1, "words": ["<tag1>", "There", "are", "a", "small", "number", "of", "suppliers", "for", "certain", "capital", "equipment", "and", "raw", "materials", "that", "we", "use", "to", "manufacture", "our", "drugs.", "<tag2>", "There", "are", "currently", "several", "marketed", "products", "for", "EPI", "caused", "by", "cystic", "fibrosis,", "including", "Creon", "marketed", "by", "AbbVie,", "Inc.,", "Pancreaze", "by", "Janssen", "Pharmaceuticals,", "Inc.,", "Pertzye", "by", "Cornestone", "Therapeutics,", "Inc.,", "and", "Ultresa", "and", "Zenpep", "by", "Aptalis", "Pharma", "US.", "<tag3>"], "wordsA": ["There", "are", "a", "small", "number", "of", "suppliers", "for", "certain", "capital", "equipment", "and", "raw", "materials", "that", "we", "use", "to", "manufacture", "our", "drugs."], "wordsB": ["There", "are", "currently", "several", "marketed", "products", "for", "EPI", "caused", "by", "cystic", "fibrosis,", "including", "Creon", "marketed", "by", "AbbVie,", "Inc.,", "Pancreaze", "by", "Janssen", "Pharmaceuticals,", "Inc.,", "Pertzye", "by", "Cornestone", "Therapeutics,", "Inc.,", "and", "Ultresa", "and", "Zenpep", "by", "Aptalis", "Pharma", "US."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item1a_p46_s0", "idA": "1316175_14_item1a_p88_s3", "sentA": "We do not have any control over the process or timing of the acquisition of these raw materials by our manufacturers.", "sentB": "We do not and will not have access to all information regarding the products being developed and potentially commercialized by Zenyaku, including potentially material information about clinical trial design and execution, safety reports from clinical trials, spontaneous safety reports if a product candidate is later approved and marketed, regulatory affairs, marketing and other areas known by Zenyaku.", "type": 1, "words": ["<tag1>", "We", "do", "not", "have", "any", "control", "over", "the", "process", "or", "timing", "of", "the", "acquisition", "of", "these", "raw", "materials", "by", "our", "manufacturers.", "<tag2>", "We", "do", "not", "and", "will", "not", "have", "access", "to", "all", "information", "regarding", "the", "products", "being", "developed", "and", "potentially", "commercialized", "by", "Zenyaku,", "including", "potentially", "material", "information", "about", "clinical", "trial", "design", "and", "execution,", "safety", "reports", "from", "clinical", "trials,", "spontaneous", "safety", "reports", "if", "a", "product", "candidate", "is", "later", "approved", "and", "marketed,", "regulatory", "affairs,", "marketing", "and", "other", "areas", "known", "by", "Zenyaku.", "<tag3>"], "wordsA": ["We", "do", "not", "have", "any", "control", "over", "the", "process", "or", "timing", "of", "the", "acquisition", "of", "these", "raw", "materials", "by", "our", "manufacturers."], "wordsB": ["We", "do", "not", "and", "will", "not", "have", "access", "to", "all", "information", "regarding", "the", "products", "being", "developed", "and", "potentially", "commercialized", "by", "Zenyaku,", "including", "potentially", "material", "information", "about", "clinical", "trial", "design", "and", "execution,", "safety", "reports", "from", "clinical", "trials,", "spontaneous", "safety", "reports", "if", "a", "product", "candidate", "is", "later", "approved", "and", "marketed,", "regulatory", "affairs,", "marketing", "and", "other", "areas", "known", "by", "Zenyaku."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p1_s0", "idA": "1316175_15_item1a_p112_s0", "sentA": "The degree of future protection for our proprietary rights is uncertain, and we cannot ensure that:", "sentB": "An investment in our securities involves a high degree of risk.", "type": 1, "words": ["<tag1>", "The", "degree", "of", "future", "protection", "for", "our", "proprietary", "rights", "is", "uncertain,", "and", "we", "cannot", "ensure", "that:", "<tag2>", "An", "investment", "in", "our", "securities", "involves", "a", "high", "degree", "of", "risk.", "<tag3>"], "wordsA": ["The", "degree", "of", "future", "protection", "for", "our", "proprietary", "rights", "is", "uncertain,", "and", "we", "cannot", "ensure", "that:"], "wordsB": ["An", "investment", "in", "our", "securities", "involves", "a", "high", "degree", "of", "risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p48_s2", "idA": "1316175_15_item1a_p123_s3", "sentA": "During the data exclusivity period, competitors are barred from relying on the innovator biologic s safety and efficacy data to gain approval.", "sentB": "In 2015, new efficacy data with a subcutaneous presentation of Benlysta were presented, along with safety and pharmacokinetics data for an autoinjector for the subcutaneous product.", "type": 1, "words": ["<tag1>", "During", "the", "data", "exclusivity", "period,", "competitors", "are", "barred", "from", "relying", "on", "the", "innovator", "biologic", "s", "safety", "and", "efficacy", "data", "to", "gain", "approval.", "<tag2>", "In", "2015,", "new", "efficacy", "data", "with", "a", "subcutaneous", "presentation", "of", "Benlysta", "were", "presented,", "along", "with", "safety", "and", "pharmacokinetics", "data", "for", "an", "autoinjector", "for", "the", "subcutaneous", "product.", "<tag3>"], "wordsA": ["During", "the", "data", "exclusivity", "period,", "competitors", "are", "barred", "from", "relying", "on", "the", "innovator", "biologic", "s", "safety", "and", "efficacy", "data", "to", "gain", "approval."], "wordsB": ["In", "2015,", "new", "efficacy", "data", "with", "a", "subcutaneous", "presentation", "of", "Benlysta", "were", "presented,", "along", "with", "safety", "and", "pharmacokinetics", "data", "for", "an", "autoinjector", "for", "the", "subcutaneous", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p1_s2", "idA": "1316175_15_item1a_p19_s0", "sentA": "place us at a competitive disadvantage when compared to our competitors who are not similarly restricted.", "sentB": "The risks and uncertainties described below are not the only ones we face.", "type": 1, "words": ["<tag1>", "place", "us", "at", "a", "competitive", "disadvantage", "when", "compared", "to", "our", "competitors", "who", "are", "not", "similarly", "restricted.", "<tag2>", "The", "risks", "and", "uncertainties", "described", "below", "are", "not", "the", "only", "ones", "we", "face.", "<tag3>"], "wordsA": ["place", "us", "at", "a", "competitive", "disadvantage", "when", "compared", "to", "our", "competitors", "who", "are", "not", "similarly", "restricted."], "wordsB": ["The", "risks", "and", "uncertainties", "described", "below", "are", "not", "the", "only", "ones", "we", "face."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p17_s1", "idA": "1316175_15_item1a_p26_s1", "sentA": "Before obtaining regulatory approvals for the commercial sale of any product candidates for a target indication, we must demonstrate with substantial evidence gathered in preclinical and well- controlled clinical studies, and, with respect to approval in the United States, to the satisfaction of the U.S. FDA and, with respect to approval in other countries, similar regulatory authorities in those countries, that the product candidates are safe and effective for use for that target indication and that the manufacturing facilities, processes and controls are adequate.", "sentB": "Under the research award agreement, we are obligated to pay royalties to CFFT as follows: i) a one-time royalty in an amount equal to the five times the award, payable in three installments between the first and second anniversaries of the first commercial sale of a product; ii) a one-time royalty in an amount equal to the actual award after net product sales reaches $100 million; and iii) in the event of a license, sale or other transfer of the product or a change of control transaction prior to the commercial sale of the product, a milestone payment equal to three times the actual award.", "type": 1, "words": ["<tag1>", "Before", "obtaining", "regulatory", "approvals", "for", "the", "commercial", "sale", "of", "any", "product", "candidates", "for", "a", "target", "indication,", "we", "must", "demonstrate", "with", "substantial", "evidence", "gathered", "in", "preclinical", "and", "well-", "controlled", "clinical", "studies,", "and,", "with", "respect", "to", "approval", "in", "the", "United", "States,", "to", "the", "satisfaction", "of", "the", "U.S.", "FDA", "and,", "with", "respect", "to", "approval", "in", "other", "countries,", "similar", "regulatory", "authorities", "in", "those", "countries,", "that", "the", "product", "candidates", "are", "safe", "and", "effective", "for", "use", "for", "that", "target", "indication", "and", "that", "the", "manufacturing", "facilities,", "processes", "and", "controls", "are", "adequate.", "<tag2>", "Under", "the", "research", "award", "agreement,", "we", "are", "obligated", "to", "pay", "royalties", "to", "CFFT", "as", "follows:", "i)", "a", "one-time", "royalty", "in", "an", "amount", "equal", "to", "the", "five", "times", "the", "award,", "payable", "in", "three", "installments", "between", "the", "first", "and", "second", "anniversaries", "of", "the", "first", "commercial", "sale", "of", "a", "product;", "ii)", "a", "one-time", "royalty", "in", "an", "amount", "equal", "to", "the", "actual", "award", "after", "net", "product", "sales", "reaches", "$100", "million;", "and", "iii)", "in", "the", "event", "of", "a", "license,", "sale", "or", "other", "transfer", "of", "the", "product", "or", "a", "change", "of", "control", "transaction", "prior", "to", "the", "commercial", "sale", "of", "the", "product,", "a", "milestone", "payment", "equal", "to", "three", "times", "the", "actual", "award.", "<tag3>"], "wordsA": ["Before", "obtaining", "regulatory", "approvals", "for", "the", "commercial", "sale", "of", "any", "product", "candidates", "for", "a", "target", "indication,", "we", "must", "demonstrate", "with", "substantial", "evidence", "gathered", "in", "preclinical", "and", "well-", "controlled", "clinical", "studies,", "and,", "with", "respect", "to", "approval", "in", "the", "United", "States,", "to", "the", "satisfaction", "of", "the", "U.S.", "FDA", "and,", "with", "respect", "to", "approval", "in", "other", "countries,", "similar", "regulatory", "authorities", "in", "those", "countries,", "that", "the", "product", "candidates", "are", "safe", "and", "effective", "for", "use", "for", "that", "target", "indication", "and", "that", "the", "manufacturing", "facilities,", "processes", "and", "controls", "are", "adequate."], "wordsB": ["Under", "the", "research", "award", "agreement,", "we", "are", "obligated", "to", "pay", "royalties", "to", "CFFT", "as", "follows:", "i)", "a", "one-time", "royalty", "in", "an", "amount", "equal", "to", "the", "five", "times", "the", "award,", "payable", "in", "three", "installments", "between", "the", "first", "and", "second", "anniversaries", "of", "the", "first", "commercial", "sale", "of", "a", "product;", "ii)", "a", "one-time", "royalty", "in", "an", "amount", "equal", "to", "the", "actual", "award", "after", "net", "product", "sales", "reaches", "$100", "million;", "and", "iii)", "in", "the", "event", "of", "a", "license,", "sale", "or", "other", "transfer", "of", "the", "product", "or", "a", "change", "of", "control", "transaction", "prior", "to", "the", "commercial", "sale", "of", "the", "product,", "a", "milestone", "payment", "equal", "to", "three", "times", "the", "actual", "award."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p3_s0", "idA": "1316175_15_item1a_p27_s0", "sentA": "We are not permitted to market our product candidates in the United States until the U.S. FDA approves our biologics license applications, or BLAs, or in any foreign countries until we receive the requisite approval from such countries.", "sentB": "We are a clinical-stage biotechnology company with two clinical assets in the late stage of development.", "type": 1, "words": ["<tag1>", "We", "are", "not", "permitted", "to", "market", "our", "product", "candidates", "in", "the", "United", "States", "until", "the", "U.S.", "FDA", "approves", "our", "biologics", "license", "applications,", "or", "BLAs,", "or", "in", "any", "foreign", "countries", "until", "we", "receive", "the", "requisite", "approval", "from", "such", "countries.", "<tag2>", "We", "are", "a", "clinical-stage", "biotechnology", "company", "with", "two", "clinical", "assets", "in", "the", "late", "stage", "of", "development.", "<tag3>"], "wordsA": ["We", "are", "not", "permitted", "to", "market", "our", "product", "candidates", "in", "the", "United", "States", "until", "the", "U.S.", "FDA", "approves", "our", "biologics", "license", "applications,", "or", "BLAs,", "or", "in", "any", "foreign", "countries", "until", "we", "receive", "the", "requisite", "approval", "from", "such", "countries."], "wordsB": ["We", "are", "a", "clinical-stage", "biotechnology", "company", "with", "two", "clinical", "assets", "in", "the", "late", "stage", "of", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p4_s0", "idA": "1316175_15_item1a_p51_s0", "sentA": "The pharmaceutical industry is highly competitive and subject to rapid and significant technological change.", "sentB": "Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate effect or an acceptable safety profile, gain regulatory approval and become commercially viable.", "type": 1, "words": ["<tag1>", "The", "pharmaceutical", "industry", "is", "highly", "competitive", "and", "subject", "to", "rapid", "and", "significant", "technological", "change.", "<tag2>", "Investment", "in", "biopharmaceutical", "product", "development", "is", "highly", "speculative", "because", "it", "entails", "substantial", "upfront", "capital", "expenditures", "and", "significant", "risk", "that", "any", "potential", "product", "candidate", "will", "fail", "to", "demonstrate", "adequate", "effect", "or", "an", "acceptable", "safety", "profile,", "gain", "regulatory", "approval", "and", "become", "commercially", "viable.", "<tag3>"], "wordsA": ["The", "pharmaceutical", "industry", "is", "highly", "competitive", "and", "subject", "to", "rapid", "and", "significant", "technological", "change."], "wordsB": ["Investment", "in", "biopharmaceutical", "product", "development", "is", "highly", "speculative", "because", "it", "entails", "substantial", "upfront", "capital", "expenditures", "and", "significant", "risk", "that", "any", "potential", "product", "candidate", "will", "fail", "to", "demonstrate", "adequate", "effect", "or", "an", "acceptable", "safety", "profile,", "gain", "regulatory", "approval", "and", "become", "commercially", "viable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p1_s1", "idA": "1316175_15_item1a_p90_s0", "sentA": "If we use hazardous and biological materials in a manner that causes injury or violates applicable law, we may be liable for damages.", "sentB": "We operate in a dynamic and rapidly changing industry that involves numerous risks and uncertainties.", "type": 1, "words": ["<tag1>", "If", "we", "use", "hazardous", "and", "biological", "materials", "in", "a", "manner", "that", "causes", "injury", "or", "violates", "applicable", "law,", "we", "may", "be", "liable", "for", "damages.", "<tag2>", "We", "operate", "in", "a", "dynamic", "and", "rapidly", "changing", "industry", "that", "involves", "numerous", "risks", "and", "uncertainties.", "<tag3>"], "wordsA": ["If", "we", "use", "hazardous", "and", "biological", "materials", "in", "a", "manner", "that", "causes", "injury", "or", "violates", "applicable", "law,", "we", "may", "be", "liable", "for", "damages."], "wordsB": ["We", "operate", "in", "a", "dynamic", "and", "rapidly", "changing", "industry", "that", "involves", "numerous", "risks", "and", "uncertainties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item1a_p7_s2", "idA": "1316175_15_item1a_p91_s0", "sentA": "Our research and development activities involve the controlled use of potentially hazardous substances, including toxic chemical and biological materials.", "sentB": "For the year ended December 31, 2015, we recognized collaborative revenue related to the amortization of upfront license fee and reimbursement for our internal full time equivalent ( FTE ) employee and certain research and development expenses by Zenyaku.", "type": 1, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "the", "controlled", "use", "of", "potentially", "hazardous", "substances,", "including", "toxic", "chemical", "and", "biological", "materials.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2015,", "we", "recognized", "collaborative", "revenue", "related", "to", "the", "amortization", "of", "upfront", "license", "fee", "and", "reimbursement", "for", "our", "internal", "full", "time", "equivalent", "(", "FTE", ")", "employee", "and", "certain", "research", "and", "development", "expenses", "by", "Zenyaku.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "the", "controlled", "use", "of", "potentially", "hazardous", "substances,", "including", "toxic", "chemical", "and", "biological", "materials."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2015,", "we", "recognized", "collaborative", "revenue", "related", "to", "the", "amortization", "of", "upfront", "license", "fee", "and", "reimbursement", "for", "our", "internal", "full", "time", "equivalent", "(", "FTE", ")", "employee", "and", "certain", "research", "and", "development", "expenses", "by", "Zenyaku."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p98_s2", "idA": "1316175_16_item1a_p124_s0", "sentA": "Litigation or patent interference proceedings may be necessarily brought against third parties, as discussed below, to enforce any of our patents or other proprietary rights or to determine the scope and validity or enforceability of the proprietary rights of such third parties.", "sentB": "cv-715, on behalf of a putative class of the Company s stockholders against the Company and certain of its current and former officers, as discussed in Item 3.", "type": 1, "words": ["<tag1>", "Litigation", "or", "patent", "interference", "proceedings", "may", "be", "necessarily", "brought", "against", "third", "parties,", "as", "discussed", "below,", "to", "enforce", "any", "of", "our", "patents", "or", "other", "proprietary", "rights", "or", "to", "determine", "the", "scope", "and", "validity", "or", "enforceability", "of", "the", "proprietary", "rights", "of", "such", "third", "parties.", "<tag2>", "cv-715,", "on", "behalf", "of", "a", "putative", "class", "of", "the", "Company", "s", "stockholders", "against", "the", "Company", "and", "certain", "of", "its", "current", "and", "former", "officers,", "as", "discussed", "in", "Item", "3.", "<tag3>"], "wordsA": ["Litigation", "or", "patent", "interference", "proceedings", "may", "be", "necessarily", "brought", "against", "third", "parties,", "as", "discussed", "below,", "to", "enforce", "any", "of", "our", "patents", "or", "other", "proprietary", "rights", "or", "to", "determine", "the", "scope", "and", "validity", "or", "enforceability", "of", "the", "proprietary", "rights", "of", "such", "third", "parties."], "wordsB": ["cv-715,", "on", "behalf", "of", "a", "putative", "class", "of", "the", "Company", "s", "stockholders", "against", "the", "Company", "and", "certain", "of", "its", "current", "and", "former", "officers,", "as", "discussed", "in", "Item", "3."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p100_s2", "idA": "1316175_16_item1a_p133_s1", "sentA": "Investor trading patterns could serve to exacerbate the volatility of the price of the stock.", "sentB": "These requirements include maintaining a minimum closing bid price of $1.00 per share.", "type": 1, "words": ["<tag1>", "Investor", "trading", "patterns", "could", "serve", "to", "exacerbate", "the", "volatility", "of", "the", "price", "of", "the", "stock.", "<tag2>", "These", "requirements", "include", "maintaining", "a", "minimum", "closing", "bid", "price", "of", "$1.00", "per", "share.", "<tag3>"], "wordsA": ["Investor", "trading", "patterns", "could", "serve", "to", "exacerbate", "the", "volatility", "of", "the", "price", "of", "the", "stock."], "wordsB": ["These", "requirements", "include", "maintaining", "a", "minimum", "closing", "bid", "price", "of", "$1.00", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p133_s0", "idA": "1316175_16_item1a_p133_s2", "sentA": "Accordingly, it may be difficult to sell shares of common stock quickly without significantly depressing the value of the stock.", "sentB": "The Company is not required to issue any shares of common stock upon conversion of any shares of Series X Convertible Preferred Stock to the extent that (i) the aggregate issuance of common stock will be greater than 8,385,828 shares or 19.99% of the total outstanding shares of the Company and (ii) the conversion has not been approved by the Company s stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635(d) (a Blocked Conversion ).", "type": 1, "words": ["<tag1>", "Accordingly,", "it", "may", "be", "difficult", "to", "sell", "shares", "of", "common", "stock", "quickly", "without", "significantly", "depressing", "the", "value", "of", "the", "stock.", "<tag2>", "The", "Company", "is", "not", "required", "to", "issue", "any", "shares", "of", "common", "stock", "upon", "conversion", "of", "any", "shares", "of", "Series", "X", "Convertible", "Preferred", "Stock", "to", "the", "extent", "that", "(i)", "the", "aggregate", "issuance", "of", "common", "stock", "will", "be", "greater", "than", "8,385,828", "shares", "or", "19.99%", "of", "the", "total", "outstanding", "shares", "of", "the", "Company", "and", "(ii)", "the", "conversion", "has", "not", "been", "approved", "by", "the", "Company", "s", "stockholders", "in", "accordance", "with", "the", "stockholder", "approval", "requirements", "of", "Nasdaq", "Marketplace", "Rule", "5635(d)", "(a", "Blocked", "Conversion", ").", "<tag3>"], "wordsA": ["Accordingly,", "it", "may", "be", "difficult", "to", "sell", "shares", "of", "common", "stock", "quickly", "without", "significantly", "depressing", "the", "value", "of", "the", "stock."], "wordsB": ["The", "Company", "is", "not", "required", "to", "issue", "any", "shares", "of", "common", "stock", "upon", "conversion", "of", "any", "shares", "of", "Series", "X", "Convertible", "Preferred", "Stock", "to", "the", "extent", "that", "(i)", "the", "aggregate", "issuance", "of", "common", "stock", "will", "be", "greater", "than", "8,385,828", "shares", "or", "19.99%", "of", "the", "total", "outstanding", "shares", "of", "the", "Company", "and", "(ii)", "the", "conversion", "has", "not", "been", "approved", "by", "the", "Company", "s", "stockholders", "in", "accordance", "with", "the", "stockholder", "approval", "requirements", "of", "Nasdaq", "Marketplace", "Rule", "5635(d)", "(a", "Blocked", "Conversion", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p100_s4", "idA": "1316175_16_item1a_p134_s0", "sentA": "In the past, securities class action litigation has often been brought against a company after a period of volatility in the market price of its common stock.", "sentB": "The letter stated that Nasdaq will provide the Company a grace period of 180 calendar days, or until August 9, 2017, to regain compliance.", "type": 1, "words": ["<tag1>", "In", "the", "past,", "securities", "class", "action", "litigation", "has", "often", "been", "brought", "against", "a", "company", "after", "a", "period", "of", "volatility", "in", "the", "market", "price", "of", "its", "common", "stock.", "<tag2>", "The", "letter", "stated", "that", "Nasdaq", "will", "provide", "the", "Company", "a", "grace", "period", "of", "180", "calendar", "days,", "or", "until", "August", "9,", "2017,", "to", "regain", "compliance.", "<tag3>"], "wordsA": ["In", "the", "past,", "securities", "class", "action", "litigation", "has", "often", "been", "brought", "against", "a", "company", "after", "a", "period", "of", "volatility", "in", "the", "market", "price", "of", "its", "common", "stock."], "wordsB": ["The", "letter", "stated", "that", "Nasdaq", "will", "provide", "the", "Company", "a", "grace", "period", "of", "180", "calendar", "days,", "or", "until", "August", "9,", "2017,", "to", "regain", "compliance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p133_s1", "idA": "1316175_16_item1a_p138_s3", "sentA": "Sales by these stockholders or option holders of a substantial number of shares could significantly reduce the market price of our common stock.", "sentB": "In the event that a Blocked Conversion occurs after April 30, 2017, the holders of shares of Series X Convertible Preferred Stock who are not able to convert their Series X Convertible Preferred Stock in full because of the Blocked Conversion shall have the right to require the Company to redeem any or all of the Series X Convertible Preferred Stock that is ineligible for conversion at a redemption price equal to the product of: (x) the number of their shares underlying the to-be-redeemed Series X Convertible Preferred Stock, multiplied by (y) the two-day volume weighted average price of the Company s common stock prior to the date of delivery of such notice of redemption.", "type": 1, "words": ["<tag1>", "Sales", "by", "these", "stockholders", "or", "option", "holders", "of", "a", "substantial", "number", "of", "shares", "could", "significantly", "reduce", "the", "market", "price", "of", "our", "common", "stock.", "<tag2>", "In", "the", "event", "that", "a", "Blocked", "Conversion", "occurs", "after", "April", "30,", "2017,", "the", "holders", "of", "shares", "of", "Series", "X", "Convertible", "Preferred", "Stock", "who", "are", "not", "able", "to", "convert", "their", "Series", "X", "Convertible", "Preferred", "Stock", "in", "full", "because", "of", "the", "Blocked", "Conversion", "shall", "have", "the", "right", "to", "require", "the", "Company", "to", "redeem", "any", "or", "all", "of", "the", "Series", "X", "Convertible", "Preferred", "Stock", "that", "is", "ineligible", "for", "conversion", "at", "a", "redemption", "price", "equal", "to", "the", "product", "of:", "(x)", "the", "number", "of", "their", "shares", "underlying", "the", "to-be-redeemed", "Series", "X", "Convertible", "Preferred", "Stock,", "multiplied", "by", "(y)", "the", "two-day", "volume", "weighted", "average", "price", "of", "the", "Company", "s", "common", "stock", "prior", "to", "the", "date", "of", "delivery", "of", "such", "notice", "of", "redemption.", "<tag3>"], "wordsA": ["Sales", "by", "these", "stockholders", "or", "option", "holders", "of", "a", "substantial", "number", "of", "shares", "could", "significantly", "reduce", "the", "market", "price", "of", "our", "common", "stock."], "wordsB": ["In", "the", "event", "that", "a", "Blocked", "Conversion", "occurs", "after", "April", "30,", "2017,", "the", "holders", "of", "shares", "of", "Series", "X", "Convertible", "Preferred", "Stock", "who", "are", "not", "able", "to", "convert", "their", "Series", "X", "Convertible", "Preferred", "Stock", "in", "full", "because", "of", "the", "Blocked", "Conversion", "shall", "have", "the", "right", "to", "require", "the", "Company", "to", "redeem", "any", "or", "all", "of", "the", "Series", "X", "Convertible", "Preferred", "Stock", "that", "is", "ineligible", "for", "conversion", "at", "a", "redemption", "price", "equal", "to", "the", "product", "of:", "(x)", "the", "number", "of", "their", "shares", "underlying", "the", "to-be-redeemed", "Series", "X", "Convertible", "Preferred", "Stock,", "multiplied", "by", "(y)", "the", "two-day", "volume", "weighted", "average", "price", "of", "the", "Company", "s", "common", "stock", "prior", "to", "the", "date", "of", "delivery", "of", "such", "notice", "of", "redemption."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p131_s2", "idA": "1316175_16_item1a_p140_s0", "sentA": "In addition, we may sell shares of stock pursuant to an equity purchase agreement with LPC executed in March 2015, pursuant to which we have the right, but not the obligation, to sell to LPC up to an aggregate of $6.0 million of common stock until March 2017.", "sentB": "of Form S-3, which imposes a limitation on the maximum amount of securities that we may sell pursuant to the registration statement during any twelve-month period.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "may", "sell", "shares", "of", "stock", "pursuant", "to", "an", "equity", "purchase", "agreement", "with", "LPC", "executed", "in", "March", "2015,", "pursuant", "to", "which", "we", "have", "the", "right,", "but", "not", "the", "obligation,", "to", "sell", "to", "LPC", "up", "to", "an", "aggregate", "of", "$6.0", "million", "of", "common", "stock", "until", "March", "2017.", "<tag2>", "of", "Form", "S-3,", "which", "imposes", "a", "limitation", "on", "the", "maximum", "amount", "of", "securities", "that", "we", "may", "sell", "pursuant", "to", "the", "registration", "statement", "during", "any", "twelve-month", "period.", "<tag3>"], "wordsA": ["In", "addition,", "we", "may", "sell", "shares", "of", "stock", "pursuant", "to", "an", "equity", "purchase", "agreement", "with", "LPC", "executed", "in", "March", "2015,", "pursuant", "to", "which", "we", "have", "the", "right,", "but", "not", "the", "obligation,", "to", "sell", "to", "LPC", "up", "to", "an", "aggregate", "of", "$6.0", "million", "of", "common", "stock", "until", "March", "2017."], "wordsB": ["of", "Form", "S-3,", "which", "imposes", "a", "limitation", "on", "the", "maximum", "amount", "of", "securities", "that", "we", "may", "sell", "pursuant", "to", "the", "registration", "statement", "during", "any", "twelve-month", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p132_s0", "idA": "1316175_16_item1a_p145_s3", "sentA": "We must also bear all of the internal and external costs of preparing and distributing periodic public reports in compliance with our obligations under the securities laws.", "sentB": "have the right to require the Company to redeem any or all of the Series X Convertible Preferred Stock that is ineligible for conversion.", "type": 1, "words": ["<tag1>", "We", "must", "also", "bear", "all", "of", "the", "internal", "and", "external", "costs", "of", "preparing", "and", "distributing", "periodic", "public", "reports", "in", "compliance", "with", "our", "obligations", "under", "the", "securities", "laws.", "<tag2>", "have", "the", "right", "to", "require", "the", "Company", "to", "redeem", "any", "or", "all", "of", "the", "Series", "X", "Convertible", "Preferred", "Stock", "that", "is", "ineligible", "for", "conversion.", "<tag3>"], "wordsA": ["We", "must", "also", "bear", "all", "of", "the", "internal", "and", "external", "costs", "of", "preparing", "and", "distributing", "periodic", "public", "reports", "in", "compliance", "with", "our", "obligations", "under", "the", "securities", "laws."], "wordsB": ["have", "the", "right", "to", "require", "the", "Company", "to", "redeem", "any", "or", "all", "of", "the", "Series", "X", "Convertible", "Preferred", "Stock", "that", "is", "ineligible", "for", "conversion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p100_s1", "idA": "1316175_16_item1a_p154_s1", "sentA": "An ownership change may limit a company s ability to use its net operating loss carryforwards attributable to the period prior to such change.", "sentB": "NASDAQ has minimum requirements that a company must meet in order to remain listed on NASDAQ.", "type": 1, "words": ["<tag1>", "An", "ownership", "change", "may", "limit", "a", "company", "s", "ability", "to", "use", "its", "net", "operating", "loss", "carryforwards", "attributable", "to", "the", "period", "prior", "to", "such", "change.", "<tag2>", "NASDAQ", "has", "minimum", "requirements", "that", "a", "company", "must", "meet", "in", "order", "to", "remain", "listed", "on", "NASDAQ.", "<tag3>"], "wordsA": ["An", "ownership", "change", "may", "limit", "a", "company", "s", "ability", "to", "use", "its", "net", "operating", "loss", "carryforwards", "attributable", "to", "the", "period", "prior", "to", "such", "change."], "wordsB": ["NASDAQ", "has", "minimum", "requirements", "that", "a", "company", "must", "meet", "in", "order", "to", "remain", "listed", "on", "NASDAQ."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p102_s2", "idA": "1316175_16_item1a_p1_s5", "sentA": "This could cause the value of our securities to decline, and you may lose all or part of your investment.", "sentB": "Under these rules, broker-dealers who recommend such securities to persons other than institutional accredited investors must:", "type": 1, "words": ["<tag1>", "This", "could", "cause", "the", "value", "of", "our", "securities", "to", "decline,", "and", "you", "may", "lose", "all", "or", "part", "of", "your", "investment.", "<tag2>", "Under", "these", "rules,", "broker-dealers", "who", "recommend", "such", "securities", "to", "persons", "other", "than", "institutional", "accredited", "investors", "must:", "<tag3>"], "wordsA": ["This", "could", "cause", "the", "value", "of", "our", "securities", "to", "decline,", "and", "you", "may", "lose", "all", "or", "part", "of", "your", "investment."], "wordsB": ["Under", "these", "rules,", "broker-dealers", "who", "recommend", "such", "securities", "to", "persons", "other", "than", "institutional", "accredited", "investors", "must:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p98_s4", "idA": "1316175_16_item1a_p30_s2", "sentA": "Negative or inconclusive results or adverse medical events during a clinical study could also cause the U.S. FDA or us to terminate a clinical study or require that we repeat it or conduct additional clinical studies.", "sentB": "Any adverse determination in litigation could also subject us to significant liabilities.", "type": 1, "words": ["<tag1>", "Negative", "or", "inconclusive", "results", "or", "adverse", "medical", "events", "during", "a", "clinical", "study", "could", "also", "cause", "the", "U.S.", "FDA", "or", "us", "to", "terminate", "a", "clinical", "study", "or", "require", "that", "we", "repeat", "it", "or", "conduct", "additional", "clinical", "studies.", "<tag2>", "Any", "adverse", "determination", "in", "litigation", "could", "also", "subject", "us", "to", "significant", "liabilities.", "<tag3>"], "wordsA": ["Negative", "or", "inconclusive", "results", "or", "adverse", "medical", "events", "during", "a", "clinical", "study", "could", "also", "cause", "the", "U.S.", "FDA", "or", "us", "to", "terminate", "a", "clinical", "study", "or", "require", "that", "we", "repeat", "it", "or", "conduct", "additional", "clinical", "studies."], "wordsB": ["Any", "adverse", "determination", "in", "litigation", "could", "also", "subject", "us", "to", "significant", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p133_s3", "idA": "1316175_16_item1a_p44_s0", "sentA": "If we fail to meet these obligations, our licensors may terminate our licenses and may be able to re-obtain licensed technologies and aspects of any intellectual properties controlled by us that relate to the licensed technologies that originated from our licensors.", "sentB": "Such forced redemption would be an additional cost to the Company and may negative affect its stock price.", "type": 1, "words": ["<tag1>", "If", "we", "fail", "to", "meet", "these", "obligations,", "our", "licensors", "may", "terminate", "our", "licenses", "and", "may", "be", "able", "to", "re-obtain", "licensed", "technologies", "and", "aspects", "of", "any", "intellectual", "properties", "controlled", "by", "us", "that", "relate", "to", "the", "licensed", "technologies", "that", "originated", "from", "our", "licensors.", "<tag2>", "Such", "forced", "redemption", "would", "be", "an", "additional", "cost", "to", "the", "Company", "and", "may", "negative", "affect", "its", "stock", "price.", "<tag3>"], "wordsA": ["If", "we", "fail", "to", "meet", "these", "obligations,", "our", "licensors", "may", "terminate", "our", "licenses", "and", "may", "be", "able", "to", "re-obtain", "licensed", "technologies", "and", "aspects", "of", "any", "intellectual", "properties", "controlled", "by", "us", "that", "relate", "to", "the", "licensed", "technologies", "that", "originated", "from", "our", "licensors."], "wordsB": ["Such", "forced", "redemption", "would", "be", "an", "additional", "cost", "to", "the", "Company", "and", "may", "negative", "affect", "its", "stock", "price."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p103_s0", "idA": "1316175_16_item1a_p56_s1", "sentA": "We cannot assure you that the regulatory agencies will complete their review processes in a timely manner or that we will obtain regulatory approval for any product candidates we develop.", "sentB": "obtain a signed and dated acknowledgement from the purchaser demonstrating that the purchaser has actually received the required risk disclosure document before a transaction in a penny stock can be completed.", "type": 1, "words": ["<tag1>", "We", "cannot", "assure", "you", "that", "the", "regulatory", "agencies", "will", "complete", "their", "review", "processes", "in", "a", "timely", "manner", "or", "that", "we", "will", "obtain", "regulatory", "approval", "for", "any", "product", "candidates", "we", "develop.", "<tag2>", "obtain", "a", "signed", "and", "dated", "acknowledgement", "from", "the", "purchaser", "demonstrating", "that", "the", "purchaser", "has", "actually", "received", "the", "required", "risk", "disclosure", "document", "before", "a", "transaction", "in", "a", "penny", "stock", "can", "be", "completed.", "<tag3>"], "wordsA": ["We", "cannot", "assure", "you", "that", "the", "regulatory", "agencies", "will", "complete", "their", "review", "processes", "in", "a", "timely", "manner", "or", "that", "we", "will", "obtain", "regulatory", "approval", "for", "any", "product", "candidates", "we", "develop."], "wordsB": ["obtain", "a", "signed", "and", "dated", "acknowledgement", "from", "the", "purchaser", "demonstrating", "that", "the", "purchaser", "has", "actually", "received", "the", "required", "risk", "disclosure", "document", "before", "a", "transaction", "in", "a", "penny", "stock", "can", "be", "completed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p131_s3", "idA": "1316175_16_item1a_p81_s0", "sentA": "The use of product candidates in clinical studies and the sale of any products for which we obtain marketing approval expose us to the risk of product liability claims.", "sentB": "At the time we sell securities pursuant to the registration statement, the amount of securities to be sold plus the amount of any securities we have sold during the prior twelve months in reliance on Instruction I.B.6.", "type": 1, "words": ["<tag1>", "The", "use", "of", "product", "candidates", "in", "clinical", "studies", "and", "the", "sale", "of", "any", "products", "for", "which", "we", "obtain", "marketing", "approval", "expose", "us", "to", "the", "risk", "of", "product", "liability", "claims.", "<tag2>", "At", "the", "time", "we", "sell", "securities", "pursuant", "to", "the", "registration", "statement,", "the", "amount", "of", "securities", "to", "be", "sold", "plus", "the", "amount", "of", "any", "securities", "we", "have", "sold", "during", "the", "prior", "twelve", "months", "in", "reliance", "on", "Instruction", "I.B.6.", "<tag3>"], "wordsA": ["The", "use", "of", "product", "candidates", "in", "clinical", "studies", "and", "the", "sale", "of", "any", "products", "for", "which", "we", "obtain", "marketing", "approval", "expose", "us", "to", "the", "risk", "of", "product", "liability", "claims."], "wordsB": ["At", "the", "time", "we", "sell", "securities", "pursuant", "to", "the", "registration", "statement,", "the", "amount", "of", "securities", "to", "be", "sold", "plus", "the", "amount", "of", "any", "securities", "we", "have", "sold", "during", "the", "prior", "twelve", "months", "in", "reliance", "on", "Instruction", "I.B.6."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item1a_p101_s1", "idA": "1316175_16_item1a_p94_s2", "sentA": "In addition, as our drug development pipeline increases and matures, we will have a greater need for clinical study and commercial manufacturing capacity.", "sentB": "In addition, if delisted we would no longer be subject to NASDAQ rules, including rules requiring us to have a certain number of independent directors and to meet other corporate governance standards.", "type": 1, "words": ["<tag1>", "In", "addition,", "as", "our", "drug", "development", "pipeline", "increases", "and", "matures,", "we", "will", "have", "a", "greater", "need", "for", "clinical", "study", "and", "commercial", "manufacturing", "capacity.", "<tag2>", "In", "addition,", "if", "delisted", "we", "would", "no", "longer", "be", "subject", "to", "NASDAQ", "rules,", "including", "rules", "requiring", "us", "to", "have", "a", "certain", "number", "of", "independent", "directors", "and", "to", "meet", "other", "corporate", "governance", "standards.", "<tag3>"], "wordsA": ["In", "addition,", "as", "our", "drug", "development", "pipeline", "increases", "and", "matures,", "we", "will", "have", "a", "greater", "need", "for", "clinical", "study", "and", "commercial", "manufacturing", "capacity."], "wordsB": ["In", "addition,", "if", "delisted", "we", "would", "no", "longer", "be", "subject", "to", "NASDAQ", "rules,", "including", "rules", "requiring", "us", "to", "have", "a", "certain", "number", "of", "independent", "directors", "and", "to", "meet", "other", "corporate", "governance", "standards."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p104_s0", "idA": "1316175_17_item1a_p108_s1", "sentA": "Investor trading patterns could serve to exacerbate the volatility of the price of the stock.", "sentB": "The full impact of the ACA, any law repealing.", "type": 1, "words": ["<tag1>", "Investor", "trading", "patterns", "could", "serve", "to", "exacerbate", "the", "volatility", "of", "the", "price", "of", "the", "stock.", "<tag2>", "The", "full", "impact", "of", "the", "ACA,", "any", "law", "repealing.", "<tag3>"], "wordsA": ["Investor", "trading", "patterns", "could", "serve", "to", "exacerbate", "the", "volatility", "of", "the", "price", "of", "the", "stock."], "wordsB": ["The", "full", "impact", "of", "the", "ACA,", "any", "law", "repealing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p102_s0", "idA": "1316175_17_item1a_p111_s3", "sentA": "This concentration of ownership may have the effect of delaying, deferring or preventing a change in control, impeding a merger, consolidation, takeover or other business combination involving us, or discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of our business, even if such a transaction would benefit other stockholders.", "sentB": "CMS has recently proposed regulations that would give states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces.", "type": 1, "words": ["<tag1>", "This", "concentration", "of", "ownership", "may", "have", "the", "effect", "of", "delaying,", "deferring", "or", "preventing", "a", "change", "in", "control,", "impeding", "a", "merger,", "consolidation,", "takeover", "or", "other", "business", "combination", "involving", "us,", "or", "discouraging", "a", "potential", "acquirer", "from", "making", "a", "tender", "offer", "or", "otherwise", "attempting", "to", "obtain", "control", "of", "our", "business,", "even", "if", "such", "a", "transaction", "would", "benefit", "other", "stockholders.", "<tag2>", "CMS", "has", "recently", "proposed", "regulations", "that", "would", "give", "states", "greater", "flexibility", "in", "setting", "benchmarks", "for", "insurers", "in", "the", "individual", "and", "small", "group", "marketplaces,", "which", "may", "have", "the", "effect", "of", "relaxing", "the", "essential", "health", "benefits", "required", "under", "the", "ACA", "for", "plans", "sold", "through", "such", "marketplaces.", "<tag3>"], "wordsA": ["This", "concentration", "of", "ownership", "may", "have", "the", "effect", "of", "delaying,", "deferring", "or", "preventing", "a", "change", "in", "control,", "impeding", "a", "merger,", "consolidation,", "takeover", "or", "other", "business", "combination", "involving", "us,", "or", "discouraging", "a", "potential", "acquirer", "from", "making", "a", "tender", "offer", "or", "otherwise", "attempting", "to", "obtain", "control", "of", "our", "business,", "even", "if", "such", "a", "transaction", "would", "benefit", "other", "stockholders."], "wordsB": ["CMS", "has", "recently", "proposed", "regulations", "that", "would", "give", "states", "greater", "flexibility", "in", "setting", "benchmarks", "for", "insurers", "in", "the", "individual", "and", "small", "group", "marketplaces,", "which", "may", "have", "the", "effect", "of", "relaxing", "the", "essential", "health", "benefits", "required", "under", "the", "ACA", "for", "plans", "sold", "through", "such", "marketplaces."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p113_s0", "idA": "1316175_17_item1a_p121_s0", "sentA": "In particular, the Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures.", "sentB": "The federal Anti-Kickback Statute prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or paying remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal healthcare programs such as Medicare and Medicaid.", "type": 1, "words": ["<tag1>", "In", "particular,", "the", "Sarbanes-Oxley", "Act", "requires,", "among", "other", "things,", "that", "we", "maintain", "effective", "internal", "control", "over", "financial", "reporting", "and", "disclosure", "controls", "and", "procedures.", "<tag2>", "The", "federal", "Anti-Kickback", "Statute", "prohibits,", "among", "other", "things,", "persons", "from", "knowingly", "and", "willfully", "soliciting,", "offering,", "receiving", "or", "paying", "remuneration,", "directly", "or", "indirectly,", "in", "cash", "or", "in", "kind,", "to", "induce", "or", "reward", "either", "the", "referral", "of", "an", "individual", "for,", "or", "the", "purchase,", "order", "or", "recommendation", "of,", "any", "good", "or", "service", "for", "which", "payment", "may", "be", "made", "under", "federal", "healthcare", "programs", "such", "as", "Medicare", "and", "Medicaid.", "<tag3>"], "wordsA": ["In", "particular,", "the", "Sarbanes-Oxley", "Act", "requires,", "among", "other", "things,", "that", "we", "maintain", "effective", "internal", "control", "over", "financial", "reporting", "and", "disclosure", "controls", "and", "procedures."], "wordsB": ["The", "federal", "Anti-Kickback", "Statute", "prohibits,", "among", "other", "things,", "persons", "from", "knowingly", "and", "willfully", "soliciting,", "offering,", "receiving", "or", "paying", "remuneration,", "directly", "or", "indirectly,", "in", "cash", "or", "in", "kind,", "to", "induce", "or", "reward", "either", "the", "referral", "of", "an", "individual", "for,", "or", "the", "purchase,", "order", "or", "recommendation", "of,", "any", "good", "or", "service", "for", "which", "payment", "may", "be", "made", "under", "federal", "healthcare", "programs", "such", "as", "Medicare", "and", "Medicaid."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p99_s1", "idA": "1316175_17_item1a_p129_s2", "sentA": "We underwent an ownership change within the meaning of Section 382 ownership of the Internal Revenue Code during 2012 and as such, our net operating loss carryforwards are limited.", "sentB": "The Supreme Court s decision upheld most of the Healthcare Reform Act and determined that requiring individuals to maintain minimum essential health insurance coverage or pay a penalty to the Internal Revenue Service was within Congress s constitutional taxing authority.", "type": 1, "words": ["<tag1>", "We", "underwent", "an", "ownership", "change", "within", "the", "meaning", "of", "Section", "382", "ownership", "of", "the", "Internal", "Revenue", "Code", "during", "2012", "and", "as", "such,", "our", "net", "operating", "loss", "carryforwards", "are", "limited.", "<tag2>", "The", "Supreme", "Court", "s", "decision", "upheld", "most", "of", "the", "Healthcare", "Reform", "Act", "and", "determined", "that", "requiring", "individuals", "to", "maintain", "minimum", "essential", "health", "insurance", "coverage", "or", "pay", "a", "penalty", "to", "the", "Internal", "Revenue", "Service", "was", "within", "Congress", "s", "constitutional", "taxing", "authority.", "<tag3>"], "wordsA": ["We", "underwent", "an", "ownership", "change", "within", "the", "meaning", "of", "Section", "382", "ownership", "of", "the", "Internal", "Revenue", "Code", "during", "2012", "and", "as", "such,", "our", "net", "operating", "loss", "carryforwards", "are", "limited."], "wordsB": ["The", "Supreme", "Court", "s", "decision", "upheld", "most", "of", "the", "Healthcare", "Reform", "Act", "and", "determined", "that", "requiring", "individuals", "to", "maintain", "minimum", "essential", "health", "insurance", "coverage", "or", "pay", "a", "penalty", "to", "the", "Internal", "Revenue", "Service", "was", "within", "Congress", "s", "constitutional", "taxing", "authority."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p114_s0", "idA": "1316175_17_item1a_p131_s3", "sentA": "At the time we sell securities pursuant to the registration statement, the amount of securities to be sold plus the amount of any securities we have sold during the prior twelve months in reliance on Instruction I.B.6.", "sentB": "The federal false claims laws impose criminal and civil penalties, including those from civil whistleblower or qui tam actions pursuant to the federal False Claims Act, against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease, or conceal an obligation to pay money to the federal government.", "type": 1, "words": ["<tag1>", "At", "the", "time", "we", "sell", "securities", "pursuant", "to", "the", "registration", "statement,", "the", "amount", "of", "securities", "to", "be", "sold", "plus", "the", "amount", "of", "any", "securities", "we", "have", "sold", "during", "the", "prior", "twelve", "months", "in", "reliance", "on", "Instruction", "I.B.6.", "<tag2>", "The", "federal", "false", "claims", "laws", "impose", "criminal", "and", "civil", "penalties,", "including", "those", "from", "civil", "whistleblower", "or", "qui", "tam", "actions", "pursuant", "to", "the", "federal", "False", "Claims", "Act,", "against", "individuals", "or", "entities", "for", "knowingly", "presenting,", "or", "causing", "to", "be", "presented,", "to", "the", "federal", "government,", "claims", "for", "payment", "that", "are", "false", "or", "fraudulent", "or", "making", "a", "false", "statement", "to", "avoid,", "decrease,", "or", "conceal", "an", "obligation", "to", "pay", "money", "to", "the", "federal", "government.", "<tag3>"], "wordsA": ["At", "the", "time", "we", "sell", "securities", "pursuant", "to", "the", "registration", "statement,", "the", "amount", "of", "securities", "to", "be", "sold", "plus", "the", "amount", "of", "any", "securities", "we", "have", "sold", "during", "the", "prior", "twelve", "months", "in", "reliance", "on", "Instruction", "I.B.6."], "wordsB": ["The", "federal", "false", "claims", "laws", "impose", "criminal", "and", "civil", "penalties,", "including", "those", "from", "civil", "whistleblower", "or", "qui", "tam", "actions", "pursuant", "to", "the", "federal", "False", "Claims", "Act,", "against", "individuals", "or", "entities", "for", "knowingly", "presenting,", "or", "causing", "to", "be", "presented,", "to", "the", "federal", "government,", "claims", "for", "payment", "that", "are", "false", "or", "fraudulent", "or", "making", "a", "false", "statement", "to", "avoid,", "decrease,", "or", "conceal", "an", "obligation", "to", "pay", "money", "to", "the", "federal", "government."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p119_s0", "idA": "1316175_17_item1a_p154_s0", "sentA": "We typically develop product candidates using compounds for which we have in-licensed and original composition of matter patents and patents that claim the activities and methods for such compounds production and use to the extent known at that time.", "sentB": "Federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers.", "type": 1, "words": ["<tag1>", "We", "typically", "develop", "product", "candidates", "using", "compounds", "for", "which", "we", "have", "in-licensed", "and", "original", "composition", "of", "matter", "patents", "and", "patents", "that", "claim", "the", "activities", "and", "methods", "for", "such", "compounds", "production", "and", "use", "to", "the", "extent", "known", "at", "that", "time.", "<tag2>", "Federal", "consumer", "protection", "and", "unfair", "competition", "laws,", "which", "broadly", "regulate", "marketplace", "activities", "and", "activities", "that", "potentially", "harm", "consumers.", "<tag3>"], "wordsA": ["We", "typically", "develop", "product", "candidates", "using", "compounds", "for", "which", "we", "have", "in-licensed", "and", "original", "composition", "of", "matter", "patents", "and", "patents", "that", "claim", "the", "activities", "and", "methods", "for", "such", "compounds", "production", "and", "use", "to", "the", "extent", "known", "at", "that", "time."], "wordsB": ["Federal", "consumer", "protection", "and", "unfair", "competition", "laws,", "which", "broadly", "regulate", "marketplace", "activities", "and", "activities", "that", "potentially", "harm", "consumers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p120_s0", "idA": "1316175_17_item1a_p160_s1", "sentA": "Although we are not currently aware of any litigation or other proceedings or third-party claims of intellectual property infringement related to our product candidates, the pharmaceutical industry is characterized by extensive litigation regarding patents and other intellectual property rights.", "sentB": "Analogous state laws and regulations, such as state anti-kickback and false claims laws and transparency laws, may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers, and some state laws require pharmaceutical companies to comply with the pharmaceutical industry s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring drug manufacturers to report information related to payments to physicians and other healthcare providers or marketing expenditures and drug pricing.", "type": 1, "words": ["<tag1>", "Although", "we", "are", "not", "currently", "aware", "of", "any", "litigation", "or", "other", "proceedings", "or", "third-party", "claims", "of", "intellectual", "property", "infringement", "related", "to", "our", "product", "candidates,", "the", "pharmaceutical", "industry", "is", "characterized", "by", "extensive", "litigation", "regarding", "patents", "and", "other", "intellectual", "property", "rights.", "<tag2>", "Analogous", "state", "laws", "and", "regulations,", "such", "as", "state", "anti-kickback", "and", "false", "claims", "laws", "and", "transparency", "laws,", "may", "apply", "to", "sales", "or", "marketing", "arrangements", "and", "claims", "involving", "healthcare", "items", "or", "services", "reimbursed", "by", "non-governmental", "third-party", "payors,", "including", "private", "insurers,", "and", "some", "state", "laws", "require", "pharmaceutical", "companies", "to", "comply", "with", "the", "pharmaceutical", "industry", "s", "voluntary", "compliance", "guidelines", "and", "the", "relevant", "compliance", "guidance", "promulgated", "by", "the", "federal", "government", "in", "addition", "to", "requiring", "drug", "manufacturers", "to", "report", "information", "related", "to", "payments", "to", "physicians", "and", "other", "healthcare", "providers", "or", "marketing", "expenditures", "and", "drug", "pricing.", "<tag3>"], "wordsA": ["Although", "we", "are", "not", "currently", "aware", "of", "any", "litigation", "or", "other", "proceedings", "or", "third-party", "claims", "of", "intellectual", "property", "infringement", "related", "to", "our", "product", "candidates,", "the", "pharmaceutical", "industry", "is", "characterized", "by", "extensive", "litigation", "regarding", "patents", "and", "other", "intellectual", "property", "rights."], "wordsB": ["Analogous", "state", "laws", "and", "regulations,", "such", "as", "state", "anti-kickback", "and", "false", "claims", "laws", "and", "transparency", "laws,", "may", "apply", "to", "sales", "or", "marketing", "arrangements", "and", "claims", "involving", "healthcare", "items", "or", "services", "reimbursed", "by", "non-governmental", "third-party", "payors,", "including", "private", "insurers,", "and", "some", "state", "laws", "require", "pharmaceutical", "companies", "to", "comply", "with", "the", "pharmaceutical", "industry", "s", "voluntary", "compliance", "guidelines", "and", "the", "relevant", "compliance", "guidance", "promulgated", "by", "the", "federal", "government", "in", "addition", "to", "requiring", "drug", "manufacturers", "to", "report", "information", "related", "to", "payments", "to", "physicians", "and", "other", "healthcare", "providers", "or", "marketing", "expenditures", "and", "drug", "pricing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p174_s3", "idA": "1316175_17_item1a_p160_s2", "sentA": "Other parties may obtain patents in the future and allege that the use of our technologies infringes these patent claims or that we are employing their proprietary technology without authorization.", "sentB": "For example, there is a risk that the 12-year period of exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider Sollpura or blisibimod to be a reference product for competing products, potentially creating the opportunity for competition sooner than anticipated.", "type": 1, "words": ["<tag1>", "Other", "parties", "may", "obtain", "patents", "in", "the", "future", "and", "allege", "that", "the", "use", "of", "our", "technologies", "infringes", "these", "patent", "claims", "or", "that", "we", "are", "employing", "their", "proprietary", "technology", "without", "authorization.", "<tag2>", "For", "example,", "there", "is", "a", "risk", "that", "the", "12-year", "period", "of", "exclusivity", "could", "be", "shortened", "due", "to", "congressional", "action", "or", "otherwise,", "or", "that", "the", "FDA", "will", "not", "consider", "Sollpura", "or", "blisibimod", "to", "be", "a", "reference", "product", "for", "competing", "products,", "potentially", "creating", "the", "opportunity", "for", "competition", "sooner", "than", "anticipated.", "<tag3>"], "wordsA": ["Other", "parties", "may", "obtain", "patents", "in", "the", "future", "and", "allege", "that", "the", "use", "of", "our", "technologies", "infringes", "these", "patent", "claims", "or", "that", "we", "are", "employing", "their", "proprietary", "technology", "without", "authorization."], "wordsB": ["For", "example,", "there", "is", "a", "risk", "that", "the", "12-year", "period", "of", "exclusivity", "could", "be", "shortened", "due", "to", "congressional", "action", "or", "otherwise,", "or", "that", "the", "FDA", "will", "not", "consider", "Sollpura", "or", "blisibimod", "to", "be", "a", "reference", "product", "for", "competing", "products,", "potentially", "creating", "the", "opportunity", "for", "competition", "sooner", "than", "anticipated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p101_s1", "idA": "1316175_17_item1a_p29_s2", "sentA": "The commencement and completion of clinical studies can be delayed for a number of reasons, including delays related to:", "sentB": "Several state Attorneys General filed suit to stop the administration from terminating the subsidies, but their request for a restraining order was denied by a federal judge in California on October 25, 2017.", "type": 1, "words": ["<tag1>", "The", "commencement", "and", "completion", "of", "clinical", "studies", "can", "be", "delayed", "for", "a", "number", "of", "reasons,", "including", "delays", "related", "to:", "<tag2>", "Several", "state", "Attorneys", "General", "filed", "suit", "to", "stop", "the", "administration", "from", "terminating", "the", "subsidies,", "but", "their", "request", "for", "a", "restraining", "order", "was", "denied", "by", "a", "federal", "judge", "in", "California", "on", "October", "25,", "2017.", "<tag3>"], "wordsA": ["The", "commencement", "and", "completion", "of", "clinical", "studies", "can", "be", "delayed", "for", "a", "number", "of", "reasons,", "including", "delays", "related", "to:"], "wordsB": ["Several", "state", "Attorneys", "General", "filed", "suit", "to", "stop", "the", "administration", "from", "terminating", "the", "subsidies,", "but", "their", "request", "for", "a", "restraining", "order", "was", "denied", "by", "a", "federal", "judge", "in", "California", "on", "October", "25,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p116_s0", "idA": "1316175_17_item1a_p3_s5", "sentA": "Substantially all of our losses resulted from costs incurred in connection with our product development programs and from general and administrative costs associated with our operations.", "sentB": "The federal false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services.", "type": 1, "words": ["<tag1>", "Substantially", "all", "of", "our", "losses", "resulted", "from", "costs", "incurred", "in", "connection", "with", "our", "product", "development", "programs", "and", "from", "general", "and", "administrative", "costs", "associated", "with", "our", "operations.", "<tag2>", "The", "federal", "false", "statements", "statute", "prohibits", "knowingly", "and", "willfully", "falsifying,", "concealing", "or", "covering", "up", "a", "material", "fact", "or", "making", "any", "materially", "false", "statement", "in", "connection", "with", "the", "delivery", "of", "or", "payment", "for", "healthcare", "benefits,", "items", "or", "services.", "<tag3>"], "wordsA": ["Substantially", "all", "of", "our", "losses", "resulted", "from", "costs", "incurred", "in", "connection", "with", "our", "product", "development", "programs", "and", "from", "general", "and", "administrative", "costs", "associated", "with", "our", "operations."], "wordsB": ["The", "federal", "false", "statements", "statute", "prohibits", "knowingly", "and", "willfully", "falsifying,", "concealing", "or", "covering", "up", "a", "material", "fact", "or", "making", "any", "materially", "false", "statement", "in", "connection", "with", "the", "delivery", "of", "or", "payment", "for", "healthcare", "benefits,", "items", "or", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p85_s0", "idA": "1316175_17_item1a_p44_s5", "sentA": "Finally, the development of new treatment methods for the diseases we are targeting could render our drugs non-competitive or obsolete.", "sentB": "uncontrollable natural forces that may render the CMO temporarily or permanently incapable of manufacturing our drugs.", "type": 1, "words": ["<tag1>", "Finally,", "the", "development", "of", "new", "treatment", "methods", "for", "the", "diseases", "we", "are", "targeting", "could", "render", "our", "drugs", "non-competitive", "or", "obsolete.", "<tag2>", "uncontrollable", "natural", "forces", "that", "may", "render", "the", "CMO", "temporarily", "or", "permanently", "incapable", "of", "manufacturing", "our", "drugs.", "<tag3>"], "wordsA": ["Finally,", "the", "development", "of", "new", "treatment", "methods", "for", "the", "diseases", "we", "are", "targeting", "could", "render", "our", "drugs", "non-competitive", "or", "obsolete."], "wordsB": ["uncontrollable", "natural", "forces", "that", "may", "render", "the", "CMO", "temporarily", "or", "permanently", "incapable", "of", "manufacturing", "our", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p108_s0", "idA": "1316175_17_item1a_p56_s0", "sentA": "Even if U.S. regulatory approval is obtained, the U.S. FDA may still impose significant restrictions on a product s indicated uses or marketing or impose ongoing requirements for potentially costly post-approval studies or post-market surveillance.", "sentB": "Individual U.S. state governments have also become increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.", "type": 1, "words": ["<tag1>", "Even", "if", "U.S.", "regulatory", "approval", "is", "obtained,", "the", "U.S.", "FDA", "may", "still", "impose", "significant", "restrictions", "on", "a", "product", "s", "indicated", "uses", "or", "marketing", "or", "impose", "ongoing", "requirements", "for", "potentially", "costly", "post-approval", "studies", "or", "post-market", "surveillance.", "<tag2>", "Individual", "U.S.", "state", "governments", "have", "also", "become", "increasingly", "aggressive", "in", "passing", "legislation", "and", "implementing", "regulations", "designed", "to", "control", "pharmaceutical", "and", "biological", "product", "pricing,", "including", "price", "or", "patient", "reimbursement", "constraints,", "discounts,", "restrictions", "on", "certain", "product", "access", "and", "marketing", "cost", "disclosure", "and", "transparency", "measures,", "and,", "in", "some", "cases,", "designed", "to", "encourage", "importation", "from", "other", "countries", "and", "bulk", "purchasing.", "<tag3>"], "wordsA": ["Even", "if", "U.S.", "regulatory", "approval", "is", "obtained,", "the", "U.S.", "FDA", "may", "still", "impose", "significant", "restrictions", "on", "a", "product", "s", "indicated", "uses", "or", "marketing", "or", "impose", "ongoing", "requirements", "for", "potentially", "costly", "post-approval", "studies", "or", "post-market", "surveillance."], "wordsB": ["Individual", "U.S.", "state", "governments", "have", "also", "become", "increasingly", "aggressive", "in", "passing", "legislation", "and", "implementing", "regulations", "designed", "to", "control", "pharmaceutical", "and", "biological", "product", "pricing,", "including", "price", "or", "patient", "reimbursement", "constraints,", "discounts,", "restrictions", "on", "certain", "product", "access", "and", "marketing", "cost", "disclosure", "and", "transparency", "measures,", "and,", "in", "some", "cases,", "designed", "to", "encourage", "importation", "from", "other", "countries", "and", "bulk", "purchasing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p101_s0", "idA": "1316175_17_item1a_p6_s6", "sentA": "As a result of an early termination of the Zenyaku Agreement, we do not expect to recognize revenues under the Zenyaku Agreement beyond January 2016.", "sentB": "On October 13, 2017, President Trump signed an Executive Order terminating the cost-sharing subsidies that reimburse insurers under the ACA.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "an", "early", "termination", "of", "the", "Zenyaku", "Agreement,", "we", "do", "not", "expect", "to", "recognize", "revenues", "under", "the", "Zenyaku", "Agreement", "beyond", "January", "2016.", "<tag2>", "On", "October", "13,", "2017,", "President", "Trump", "signed", "an", "Executive", "Order", "terminating", "the", "cost-sharing", "subsidies", "that", "reimburse", "insurers", "under", "the", "ACA.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "an", "early", "termination", "of", "the", "Zenyaku", "Agreement,", "we", "do", "not", "expect", "to", "recognize", "revenues", "under", "the", "Zenyaku", "Agreement", "beyond", "January", "2016."], "wordsB": ["On", "October", "13,", "2017,", "President", "Trump", "signed", "an", "Executive", "Order", "terminating", "the", "cost-sharing", "subsidies", "that", "reimburse", "insurers", "under", "the", "ACA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p98_s0", "idA": "1316175_17_item1a_p86_s0", "sentA": "Specifically, in both the United States and some foreign jurisdictions, there have been a number of legislative and regulatory proposals to change the health care system in ways that could affect our ability to sell our products profitably.", "sentB": "Since its enactment, however, there have been modifications and challenges to numerous aspects of the ACA:", "type": 1, "words": ["<tag1>", "Specifically,", "in", "both", "the", "United", "States", "and", "some", "foreign", "jurisdictions,", "there", "have", "been", "a", "number", "of", "legislative", "and", "regulatory", "proposals", "to", "change", "the", "health", "care", "system", "in", "ways", "that", "could", "affect", "our", "ability", "to", "sell", "our", "products", "profitably.", "<tag2>", "Since", "its", "enactment,", "however,", "there", "have", "been", "modifications", "and", "challenges", "to", "numerous", "aspects", "of", "the", "ACA:", "<tag3>"], "wordsA": ["Specifically,", "in", "both", "the", "United", "States", "and", "some", "foreign", "jurisdictions,", "there", "have", "been", "a", "number", "of", "legislative", "and", "regulatory", "proposals", "to", "change", "the", "health", "care", "system", "in", "ways", "that", "could", "affect", "our", "ability", "to", "sell", "our", "products", "profitably."], "wordsB": ["Since", "its", "enactment,", "however,", "there", "have", "been", "modifications", "and", "challenges", "to", "numerous", "aspects", "of", "the", "ACA:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p115_s0", "idA": "1316175_17_item1a_p87_s0", "sentA": "In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the Health Care Reform Law, a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms.", "sentB": "The federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act, imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program and also imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information.", "type": 1, "words": ["<tag1>", "In", "March", "2010,", "President", "Obama", "signed", "into", "law", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act,", "as", "amended", "by", "the", "Health", "Care", "and", "Education", "Reconciliation", "Act,", "or", "collectively,", "the", "Health", "Care", "Reform", "Law,", "a", "sweeping", "law", "intended", "to", "broaden", "access", "to", "health", "insurance,", "reduce", "or", "constrain", "the", "growth", "of", "healthcare", "spending,", "enhance", "remedies", "against", "fraud", "and", "abuse,", "add", "new", "transparency", "requirements", "for", "healthcare", "and", "health", "insurance", "industries,", "impose", "new", "taxes", "and", "fees", "on", "the", "health", "industry", "and", "impose", "additional", "health", "policy", "reforms.", "<tag2>", "The", "federal", "Health", "Insurance", "Portability", "and", "Accountability", "Act", "of", "1996,", "as", "amended", "by", "the", "Health", "Information", "Technology", "for", "Economic", "and", "Clinical", "Health", "Act,", "imposes", "criminal", "and", "civil", "liability", "for", "executing", "a", "scheme", "to", "defraud", "any", "healthcare", "benefit", "program", "and", "also", "imposes", "obligations,", "including", "mandatory", "contractual", "terms,", "with", "respect", "to", "safeguarding", "the", "privacy,", "security", "and", "transmission", "of", "individually", "identifiable", "health", "information.", "<tag3>"], "wordsA": ["In", "March", "2010,", "President", "Obama", "signed", "into", "law", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act,", "as", "amended", "by", "the", "Health", "Care", "and", "Education", "Reconciliation", "Act,", "or", "collectively,", "the", "Health", "Care", "Reform", "Law,", "a", "sweeping", "law", "intended", "to", "broaden", "access", "to", "health", "insurance,", "reduce", "or", "constrain", "the", "growth", "of", "healthcare", "spending,", "enhance", "remedies", "against", "fraud", "and", "abuse,", "add", "new", "transparency", "requirements", "for", "healthcare", "and", "health", "insurance", "industries,", "impose", "new", "taxes", "and", "fees", "on", "the", "health", "industry", "and", "impose", "additional", "health", "policy", "reforms."], "wordsB": ["The", "federal", "Health", "Insurance", "Portability", "and", "Accountability", "Act", "of", "1996,", "as", "amended", "by", "the", "Health", "Information", "Technology", "for", "Economic", "and", "Clinical", "Health", "Act,", "imposes", "criminal", "and", "civil", "liability", "for", "executing", "a", "scheme", "to", "defraud", "any", "healthcare", "benefit", "program", "and", "also", "imposes", "obligations,", "including", "mandatory", "contractual", "terms,", "with", "respect", "to", "safeguarding", "the", "privacy,", "security", "and", "transmission", "of", "individually", "identifiable", "health", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p99_s3", "idA": "1316175_17_item1a_p88_s0", "sentA": "We will not know the full effects of the Health Care Reform Law until applicable federal and state agencies issue regulations or guidance under the new law.", "sentB": "The long ranging effects of the elimination of the individual mandate on the viability of the ACA are unknown at this time.", "type": 1, "words": ["<tag1>", "We", "will", "not", "know", "the", "full", "effects", "of", "the", "Health", "Care", "Reform", "Law", "until", "applicable", "federal", "and", "state", "agencies", "issue", "regulations", "or", "guidance", "under", "the", "new", "law.", "<tag2>", "The", "long", "ranging", "effects", "of", "the", "elimination", "of", "the", "individual", "mandate", "on", "the", "viability", "of", "the", "ACA", "are", "unknown", "at", "this", "time.", "<tag3>"], "wordsA": ["We", "will", "not", "know", "the", "full", "effects", "of", "the", "Health", "Care", "Reform", "Law", "until", "applicable", "federal", "and", "state", "agencies", "issue", "regulations", "or", "guidance", "under", "the", "new", "law."], "wordsB": ["The", "long", "ranging", "effects", "of", "the", "elimination", "of", "the", "individual", "mandate", "on", "the", "viability", "of", "the", "ACA", "are", "unknown", "at", "this", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p97_s0", "idA": "1316175_17_item1a_p91_s1", "sentA": "It will be time-consuming and expensive for us to go through the process of seeking reimbursement from Medicare and private payors.", "sentB": "establishment of a Center for Medicare and Medicaid Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending.", "type": 1, "words": ["<tag1>", "It", "will", "be", "time-consuming", "and", "expensive", "for", "us", "to", "go", "through", "the", "process", "of", "seeking", "reimbursement", "from", "Medicare", "and", "private", "payors.", "<tag2>", "establishment", "of", "a", "Center", "for", "Medicare", "and", "Medicaid", "Innovation", "at", "CMS", "to", "test", "innovative", "payment", "and", "service", "delivery", "models", "to", "lower", "Medicare", "and", "Medicaid", "spending,", "potentially", "including", "prescription", "drug", "spending.", "<tag3>"], "wordsA": ["It", "will", "be", "time-consuming", "and", "expensive", "for", "us", "to", "go", "through", "the", "process", "of", "seeking", "reimbursement", "from", "Medicare", "and", "private", "payors."], "wordsB": ["establishment", "of", "a", "Center", "for", "Medicare", "and", "Medicaid", "Innovation", "at", "CMS", "to", "test", "innovative", "payment", "and", "service", "delivery", "models", "to", "lower", "Medicare", "and", "Medicaid", "spending,", "potentially", "including", "prescription", "drug", "spending."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p100_s0", "idA": "1316175_17_item1a_p95_s1", "sentA": "The loss of the services of any of these persons might impede the achievement of our research, development and commercialization objectives.", "sentB": "On January 20, 2017, President Trump signed an Executive Order directing federal agencies with authorities and responsibilities under the ACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the ACA that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices.", "type": 1, "words": ["<tag1>", "The", "loss", "of", "the", "services", "of", "any", "of", "these", "persons", "might", "impede", "the", "achievement", "of", "our", "research,", "development", "and", "commercialization", "objectives.", "<tag2>", "On", "January", "20,", "2017,", "President", "Trump", "signed", "an", "Executive", "Order", "directing", "federal", "agencies", "with", "authorities", "and", "responsibilities", "under", "the", "ACA", "to", "waive,", "defer,", "grant", "exemptions", "from,", "or", "delay", "the", "implementation", "of", "any", "provision", "of", "the", "ACA", "that", "would", "impose", "a", "fiscal", "burden", "on", "states", "or", "a", "cost,", "fee,", "tax,", "penalty", "or", "regulatory", "burden", "on", "individuals,", "healthcare", "providers,", "health", "insurers,", "or", "manufacturers", "of", "pharmaceuticals", "or", "medical", "devices.", "<tag3>"], "wordsA": ["The", "loss", "of", "the", "services", "of", "any", "of", "these", "persons", "might", "impede", "the", "achievement", "of", "our", "research,", "development", "and", "commercialization", "objectives."], "wordsB": ["On", "January", "20,", "2017,", "President", "Trump", "signed", "an", "Executive", "Order", "directing", "federal", "agencies", "with", "authorities", "and", "responsibilities", "under", "the", "ACA", "to", "waive,", "defer,", "grant", "exemptions", "from,", "or", "delay", "the", "implementation", "of", "any", "provision", "of", "the", "ACA", "that", "would", "impose", "a", "fiscal", "burden", "on", "states", "or", "a", "cost,", "fee,", "tax,", "penalty", "or", "regulatory", "burden", "on", "individuals,", "healthcare", "providers,", "health", "insurers,", "or", "manufacturers", "of", "pharmaceuticals", "or", "medical", "devices."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item1a_p5_s0", "idA": "1316175_17_item1a_p95_s6", "sentA": "In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy.", "sentB": "hire additional clinical, scientific and management personnel, if needed.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "rely", "on", "consultants", "and", "advisors,", "including", "scientific", "and", "clinical", "advisors,", "to", "assist", "us", "in", "formulating", "our", "research", "and", "development", "and", "commercialization", "strategy.", "<tag2>", "hire", "additional", "clinical,", "scientific", "and", "management", "personnel,", "if", "needed.", "<tag3>"], "wordsA": ["In", "addition,", "we", "rely", "on", "consultants", "and", "advisors,", "including", "scientific", "and", "clinical", "advisors,", "to", "assist", "us", "in", "formulating", "our", "research", "and", "development", "and", "commercialization", "strategy."], "wordsB": ["hire", "additional", "clinical,", "scientific", "and", "management", "personnel,", "if", "needed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
